Owens & Minor
Annual Report 2013

Plain-text annual report

2013 Annual Report & Form 10-K 2 0 1 3 A N N U A L R E P O R T & F O R M 1 0 - K With a logistics network that spans the United States and Europe, Owens & Minor, Inc. (NYSE-OMI) is focused on Connecting the World of Medical Products to the Point of CareTM. While the global healthcare market is growing rapidly in size and complexity, Owens & Minor is well-positioned today to participate in the markets that account for three- fourths of the global expenditure for healthcare products and services. Building on a substantial 132-year legacy in healthcare, we are investing in development of the infrastructure, network and value-added services that will enable us to serve as a full logistics partner for healthcare. As a trusted partner to healthcare providers and manufacturers alike, we aim to provide integrated, flexible logistics solutions that improve patient care, reduce inventory and simplify logistics for our customers, all while unlocking hidden value across the supply chain. A FORTUNE 500 company, Owens & Minor, Inc. is traded on the New York Stock Exchange under the symbol OMI. Our values, which form the fundamentals of our culture, are simple: we believe in doing business with integrity, supporting our teammates, providing superior customer service and supporting our communities. Throughout our history, we have also believed in creating long-term value for our shareholders, and we are proud of our ten-year cumulative total return of 214%. For more information about Owens & Minor, please visit our website at www.owens-minor.com. “We are investing in development of the infrastructure, network and value- added services that will enable us to serve as a full logistics partner for healthcare.” FINANCIAL HIGHLIGHTS (in millions, except per share data) Year ended December 31, 2013(1) 2012(2) 2011(3) ’13/’12 ’12/’11 Percent Change Revenue Net income $9,071.5 $8,868.3 $8,627.9 2.3% 2.8% 110.9 109.0 115.2 1.7% (5.4)% Net income per common share - diluted Cash dividends per common share Book value per common share at year-end (4) Stock price per common share at year-end 1.76 0.96 16.23 36.56 1.72 0.88 15.38 28.51 1.81 0.80 14.47 9.1% 5.5% 27.79 28.2% 2.3% (5.0)% Total assets Total debt $2,324.0 $2,214.4 $1,946.8 4.9% 13.7% 216.2 217.6 214.6 (0.6)% Owens & Minor, Inc. shareholders’ equity 1,023.9 972.5 918.1 5.3% 10.0% 6.3% 2.6% 1.4% 5.9% (1) We incurred charges of $12.4 million ($8.9 million after tax, or $0.14 per common share) associated with acquisition-related and exit and realignment activities in 2013. See Notes 3 and 9 of Notes to the Consolidated Financial Statement (2) We incurred charges of $10.2 million ($8.2 million after tax, or $0.13 per common share) associated with acquisition-related and exit and realignment activities in 2012. See Notes 3 and 9 of Notes to the Consolidated Financial Statements. (3) We incurred charges of $13.2 million ($8.0 million after tax, or $0.13 per common share) associated with acquisition-related and exit and realignment activities in 2011. See Note 9 of Notes to the Consolidated Financial Statements. (4) Represents Owens & Minor, Inc. shareholders’ equity divided by year-end common shares outstanding. Revenue Net Income $8.87 $9.07 $8.63 $115.2 $109.0 $110.9 Net Income Per Diluted Share $1.81 $1.72 $1.76 Dividends $0.96 $0.88 $0.80 ) s n o i l l i B n i s r a l l o D ( ) s n o i l l i M n i s r a l l o D ( ) e r a h s n o m m o c r e p s r a l l o D ( ) e r a h s n o m m o c r e p s r a l l o D ( 2011 2012 2013 2011 2012 2013 2011 2012 2013 2011 2012 2013 1 2013 Annual Report & Form 10-K 1000 800 600 400 200 0 TO OUR SHAREHOLDERS, TEAmmATES, AND FRIENDS: “Together, our Domestic and International platforms are positioned to serve the two regions of the world where three-quarters of the global healthcare expenditure occurs – the United States and Europe.” For a company that will mark its 132nd year in operation in 2014, we can point to many achievements since we opened our doors in 1882. However, I believe that one of our most important achievements is our enduring ability to focus on the future, no matter what conditions we face in the healthcare market and in the economy. Over the generations, we have been able to chart a steady course by staying focused on delivering long-term value and making investments that will serve us well over the long run. With 2013 behind us, we accomplished most of the operational and financial goals we established for the year, and certain of these milestones illustrate our ability to move our company forward. We celebrated our first full year of operations in Europe with our Movianto team. Shareholders’ equity exceeded the $1 billion mark for the first time in 2013, and we made a record amount of shareholder distributions last year. Annual revenues exceeded $9 billion for the first time, and we reached our targeted revenue growth range on a consolidated basis, thanks to the hard work of our sales teams in the U.S. and Europe. We achieved this revenue target despite certain challenging macro economic lower conditions, rates of healthcare utilization, new healthcare legislation, and negligible price inflation on medical products. including: Despite these conditions, our Domestic teams achieved positive revenue growth in the second half of the year. And, with new leadership in place at Movianto and the hard work of our European teammates, our International segment steadily improved throughout the year. I am pleased to report that the Movianto team achieved two consecutive profitable quarters in the second half of 2013 and improved operating earnings over the course of the year. 2013 Annual Report & Form 10-K 2 Last year, we reached another milestone by completing the last of the contract renewals with the major group purchasing organizations (GPOs). Putting this 18-month process in our rear-view mirror enables us to fully concentrate on building our relationships with the individual GPO members – the provider hospitals and health systems who are our customers. During the year, we also refocused our management teams so that we have the ex- pertise and resources dedicated to serve not only our healthcare provider customers, but our manufacturer customers, as well. Our relationships with healthcare manufac- turers are important building blocks for our future. Domestically, we provide valu- able services to our manufacturers such as warehousing, distribution, sales, invoic- ing, collections, and channel access to more than 40% of the acute-care distribution market. Internationally, where our primary customers are healthcare manufacturers, we provide a range of outsourced logistics services. With our legacy expertise and re- lationships in healthcare and our established platforms on two continents, we believe we are uniquely positioned to execute our vision of Connecting the World of Medical Products to the Point of CareTM. Finally, we continued our tradition of creating value for our investors with total shareholder distributions of nearly $80 million in dividends and share repurchases in 2013. With an attractive dividend yield and new share repurchase program, we have the strategy and the means to enhance our long-term value for our shareholders. While there were many challenges in the healthcare market over the last four years, we remained focused on our future. We have invested more than $330 million in growth investments, including the acquisition of Movianto, an established, leading European healthcare logistics business. The investments we made over this period share a common focus – expanding our addressable market in healthcare and building our infrastructure to support evolving customer needs. For example, in response to a growing demand from manufacturers for logistics services, we invested in developing our healthcare logistics business. We also established a sourcing arm in Asia, which is supporting our three-pronged sourcing strategy – growing our private label, working with branded manufacturers and working with diversity suppliers. In addition, over this same time period, we distributed approximately $260 million to our shareholders. We firmly believe that these achievements over the last four years have put us in a much stronger position than ever before to embrace emerging opportunities in healthcare. Turning to our financial results for 2013, consolidated revenues grew 2.3% to $9.07 billion, including revenues of $384 million from the International segment. Offsetting this increase in International revenues was a slight decline in Domestic revenue results, primarily resulting from the continuing headwinds we cited consistently throughout the year. Adjusted consolidated operating earnings, excluding $12.4 million in pre-tax acquisition-related and exit and realignment charges, were $211 million, or 2.32% of revenues, which is an improvement of $4 million compared to the year before. The International segment narrowed its operating losses throughout the year by $4 million and reported an operating loss of $1.4 million for the year. The Movianto team did a great job in improving their performance under the guidance of the new leadership team. For the year, adjusted consolidated net income was $120 million, or $1.90 per diluted share, an improvement of five cents, when compared to the year before. In looking back, we see that 2013 was another solid year of investment in our strategy to expand our reach into the global healthcare markets and modernize our platforms so that we may continue to adapt to changes in our markets and embrace emerging opportunities. With every strategic decision we make, we know we must also deliver long-term value to our shareholders. Part of this value 74% of the global healthcare spend occurs in North America and Europe O&M’s domestic facilities are within four hours of 90% of the nation’s hospital beds 17% of the U.S. GDP is spent on healthcare 3 2013 Annual Report & Form 10-K creation comes from our capital allocation strategy. We are in the final year of a three-year, $50 million investment in upgrading and modernizing our information technology systems. This phased investment strategy is enabling us to improve our key systems and prepare for handling new types of business and services. Another important element of our capital allocation strategy is paying dividends to our shareholders. In all, this will be the 85th straight year that Owens & Minor has paid a dividend. The ten-year cumulative total return for Owens & Minor of 214% exceeds that of the S&P 500 over the same period. Already this year, our board has approved a 4% increase in our first quarter 2014 dividend and established a new, three-year, $100 million share repurchase program. This share repurchase plan gives us an additional means of returning value to shareholders. Also, as you can see from this year’s annual report, we are adapting our approach to the market in response to developments in the healthcare market and an evolution in our customer mix. Because we provide much more than traditional healthcare distribution services today, we are positioning Owens & Minor in the market as the go-to logistics provider for healthcare manufacturers and providers. Our new tag line sums it all up: HEALTHCARE LOGISTICS. EVOLVED TM. Together, our Domestic and International platforms are positioned to serve customers within the two regions of the world where three-quarters of the global healthcare expenditure occurs – North America and Europe. By expanding the range of services we provide and our customer base, we believe we are better equipped today than ever before to tap a larger portion of the global healthcare spend. This is an exciting prospect for all of us at Owens & Minor. With every passing year comes change. This year, I would like to welcome two new directors to the Owens & Minor family: Stuart M. Essig, the former chief executive officer and current board chairman of Integra LifeSciences Holdings Corporation; and David S. Simmons, chairman & chief executive officer of Pharmaceutical Product Development, LLC. We are very pleased to welcome both gentlemen to our board. Stuart and David bring a new dimension to the table with expertise in global commerce and the medical device and pharmaceutical sides of healthcare. As we welcome two new board members, we also say farewell to the long-standing chairman of our audit committee. I would like to acknowledge the generous service of Richard Fogg, who joined our board in 2003 and who has been our audit committee chairman since 2006. Dick Fogg has been a steady leader and expert resource for the company throughout his time on our board. We deeply appreciate the work he has done for Owens & Minor and the guidance he has provided. I want to personally thank Dick for his many contributions to Owens & Minor and for his friendship. I know I speak for all of us, when I wish him well as he retires from our board after our Annual Shareholders’ Meeting in May. I would also like to thank Jim Bierman for stepping into the role of president of Owens & Minor last year. Jim took on this significant new responsibility with great enthusiasm and has done an admirable job of preparing our company and our teammates for the opportunities ahead. In addition, Randy Meier joined Owens & Minor as our new chief financial officer, and his considerable experience in operating global healthcare products businesses is strengthening our efforts. Every day, we serve thousands of healthcare provider and manufacturer customers in the United States and in Europe. We work hard to expand our business, improve our earnings power and deliver value to shareholders. Our success depends directly on O&M made $80 million in shareholder distributions in 2013 Strategic investments have more than doubled O&M’s addressable market Shareholders’ equity exceeds $1,000,000,000 2013 Annual Report & Form 10-K 4 our 6,700 teammates stationed in the United States, Europe and Asia. Their hard work is the foundation of our success today, but their teamwork, expertise and energy will make an even greater impact as we prepare for our future. I commend them for their enthusiastic commitment to Owens & Minor. Our teammates are also generous volunteers, giving their time, energy and talent to serving the needs of our communities. Each year, our teammates participate in a wide range of community events, raising money and donating time to various community service organizations such as food-banks, veterans’ organizations, and schools in need. Our teammates place great value on making a positive impact in our communities. In closing, I would like to thank our shareholders, provider and manufacturer customers, and business partners for their ongoing support of Owens & Minor. And, I especially want to thank our teammates in the U.S., Europe and Asia, who serve our company with such dedication every day. I am convinced that every great success is the result of teamwork, and that is what we celebrate every day at Owens & Minor. Best wishes for a great year to come, Craig R. Smith Chairman & Chief Executive Officer “I am convinced that every great success is the result of teamwork, and that is what we celebrate every day at Owens & Minor.” O&M U.S. • Medical Devices • Buy-Sell • Provider Customers • Order Aggregation • Utilized Delivery O&M Asia • Sourcing • Product Quality • Regulatory Compliance • Manufacturer Qualification • Price, Logistics O&M Europe • RX / Biotech • Fee-for-Service • Manufacturer Customers • Cold Chain / Controlled Substances 5 2013 Annual Report & Form 10-K CONNECTING THE WORLD OF mEDICAL PRODUCTS TO THE POINT OF CARE ™ Serving the logistics needs of a healthcare market that is growing in size, scope and complexity every day demands a new approach with comprehensive, innovative services. Building on our 132-year legacy in healthcare, we are using our market leading positions in the United States and Europe to provide a fresh approach to healthcare logistics. With platforms on two continents, expertise in logistics and distribution, product sourcing capabilities, and deep relationships in healthcare, we aim to be the trusted partner that is Connecting the World of Medical Products to the Point of CareTM. Using a partnership approach, we serve healthcare providers and healthcare products manufacturers alike, by offering solutions to logistics challenges. For our healthcare provider customers, which range from large-scale, integrated healthcare networks to single hospitals, we provide a full range of logistics services, including consolidated procurement and contract management, inventory management and customized deliveries. We also provide assistance in product selection in support of healthcare providers’ patient care and financial goals. For healthcare manufacturers, we offer a wide range of logistics services across Europe and the United States, from straightforward third-party logistics and product sourcing services, 2013 Annual Report & Form 10-K 6 “Building on our 132-year legacy in healthcare, we are using our market leading positions in the United States and Europe to provide a fresh approach to healthcare logistics.” to more complex processes such as cold-chain management and regulatory oversight. As our logistics services evolve, we see new opportunities in an addressable market that has more than doubled in size. In order to tap this expanded market opportunity, we have conducted a series of strategic investments in recent years that have enabled us to update our information technology systems, add capabilities in Europe and refresh our domestic network. Our new logo says it all: HEALTHCARE LOGISTICS. EVOLVEDTM. 7 2013 Annual Report & Form 10-K THIS PAGE DOES NOT PRINT. HOLDING PAGE FOR THE FRONT OF THE 10-K BOARD OF DIRECTORS Craig R. Smith (62) 1, 4 Chairman & CEO, Owens & Minor, Inc. James E. Rogers (68) 1, 3 Lead Director, Owens & Minor, Inc. Chairman, BackOffice Associates Retired President, SCI Investors Inc. Stuart M. Essig (52) 3, 4 Chairman of the Board, Integra LifeSciences Holdings Corporation Retired CEO, Integra LifeSciences Holdings Corporation Richard E. Fogg (73) 1, 2*, 4 Retired Partner, PricewaterhouseCoopers LLP John W. Gerdelman (61) 2, 4* Managing Partner, River2 Lemuel E. Lewis (67) 2, 5 President, LocalWeather.com Retired EVP & CFO, Landmark Communications Martha H. Marsh (65) 2, 4 Retired President & CEO, Stanford Hospital and Clinics Eddie N. Moore, Jr. (66) 2, 5 Interim President & CEO, Norfolk State University Former President, Saint Paul’s College President Emeritus, Virginia State University David S. Simmons (49) 2, 4 Chairman & CEO, Pharmaceutical Product Development, LLC Robert C. Sledd (61) 1, 3*, 4, 5 Former Senior Economic Advisor to the Governor of Virginia Former Chairman, Performance Food Group Co. Anne Marie Whittemore (67) 1, 3, 5* Partner, McGuireWoods LLP Board Committees: 1Executive Committee 2Audit Committee 3Compensation & Benefits Committee 4Strategic Planning Committee 5Governance & Nominating Committee *Denotes Chairman CORPORATE OFFICERS Craig R. Smith (62) Chairman & Chief Executive Officer Chairman of the Board since April 2013 and Chief Executive Officer since 2005. Mr. Smith also served as President from 1999 until August 2013. Mr. Smith has been with the company since 1989. James L. Bierman (61) President & Chief Operating Officer President since August 2013 and Chief Operating Officer since March 2012. Previously, Mr. Bierman served as Executive Vice President & Chief Operating Officer from March 2012 until August 2013. Mr. Bierman served as Executive Vice President & Chief Financial Officer from April 2011 to March 2012. Prior to that, Mr. Bierman served as Senior Vice President & Chief Financial Officer from 2007 to 2011. Mr. Bierman joined the company in 2007. Richard A. Meier (54) Executive Vice President & Chief Financial Officer Executive Vice President & Chief Financial Officer since joining Owens & Minor in March 2013. Mr. Meier served from 2010 to 2012 as Executive Vice President & Chief Financial Officer of Teleflex, Inc., a global provider of specialty medical devices. Prior to that, he served as President & Chief Operating Officer of Advanced Medical Optics, Inc., from 2007 to 2009, and as Chief Financial Officer and in a variety of other finance and operations roles from 2002 through 2007. Charles C. Colpo (56) Senior Vice President, Strategic Relationships Senior Vice President, Strategic Relationships since August 2013. From March 2012 until August 2013, Mr. Colpo served as Senior Vice President, Operations. Prior to that, Mr. Colpo served as Executive Vice President & Chief Operating Officer from 2010 to 2012. Mr. Colpo served as Executive Vice President, Administration from 2008 until 2010 and as Senior Vice President, Operations, from 1999 until 2008. He has been with the company since 1981. Erika T. Davis (50) Senior Vice President, Administration & Operations Senior Vice President, Administration & Operations since August 2013. Prior to that, Ms. Davis served as Senior Vice President, Human Resources, from 2001 until August 2013. Ms. Davis has been with the company since 1993. Grace R. den Hartog (62) Senior Vice President, General Counsel & Corporate Secretary Senior Vice President, General Counsel & Corporate Secretary since joining Owens & Minor in 2003. Previously, Ms. den Hartog served as a partner of McGuireWoods LLP from 1990 to 2003. D. Todd Healy (51) Senior Vice President, Provider Services Senior Vice President, Provider Services since August 2013. Prior to that, Mr. Healy served as Regional Vice President, North Region from 2004 to August 2013. He has served in general manager, division vice president and area vice president positions since joining Owens & Minor in 1994. Richard W. Mears (53) Senior Vice President, Chief Information Officer Senior Vice President, Chief Information Officer since joining Owens & Minor in 2005. Previously, Mr. Mears was an Executive Director with Perot Systems (now Dell Perot Systems) from 2003 to 2005. Brian J. Shotto (50) Senior Vice President, Manufacturer Services Senior Vice President, Manufacturer Services since August 2013. Previously, Mr. Shotto served as Senior Vice President, Specialty Services from October 2011 until August 2013. Mr. Shotto served as a Principal Consultant for the Blue Fin Group from 2009 until 2011. Prior to that, he served as Vice President, Distribution Strategy – Healthcare Logistics Strategy Group, UPS, from 2006 to 2009, a company he joined in 2000. Mr. Shotto joined Owens & Minor in 2011. Mark A. Van Sumeren (56) Senior Vice President, Strategy & Business Development Senior Vice President, Strategy & Business Development since 2009 and Senior Vice President, Business Development, from 2007 to 2009. Prior to that, Mr. Van Sumeren was Senior Vice President, OMSolutionsSM from 2003 to 2006. Mr. Van Sumeren served as Vice President for Cap Gemini Ernst & Young from 2000 to 2003. He has been with the company since 2003. Numbers inside parentheses indicate age. 2013 Annual Report & Form 10-K 8 Owens & Minor, Inc. 2013 Form 10-K THIS PAGE INTENTIONALLY LEFT BLANK UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the year ended December 31, 2013 Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 1-9810 OWENS & MINOR, INC. (Exact name of registrant as specified in its charter) Virginia (State or other jurisdiction of incorporation or organization) 9120 Lockwood Boulevard, Mechanicsville, Virginia (Address of principal executive offices) 54-1701843 (I.R.S. Employer Identification No.) 23116 (Zip Code) Registrant’s telephone number, including area code (804) 723-7000 Securities registered pursuant to Section 12(b) of the Act: Title of each class Common Stock, $2 par value Preferred Stock Purchase Rights 6.35% Senior Notes due 2016 Name of each exchange on which registered New York Stock Exchange New York Stock Exchange Not Listed Securities registered pursuant to Section 12(g) of the Act: None Indicate by check mark if the registrant is a well-known seasoned issuer (as defined in Rule 405 of the Securities Act). Yes No Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes No 1 Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes No Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. Large accelerated filer Non-accelerated filer Accelerated filer Smaller reporting com pany Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No The aggregate market value of Common Stock held by non-affiliates (based upon the closing sales price) was approximately $2,142,554,205 as of June 30, 2013. The number of shares of the Company’s common stock outstanding as of February 18, 2014 was 63,097,861 shares. Documents Incorporated by Reference The proxy statement for the annual meeting of shareholders to be held on May 1, 2014, is incorporated by reference for Item 5 of Part II and Part III. 2 Form 10-K Table of Contents Item No. Part I 1 1A. 1B. Business . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Risk Factors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Unresolved Staff Comments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Properties . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Legal Proceedings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 Mine Safety Disclosures. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 2 Part II 5 6 7 7A. 8 9 9A. 9B. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Selected Consolidated Financial Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Management’s Discussion and Analysis of Financial Condition and Results of Operations. . . . . . . . . . . . . . . . Quantitative and Qualitative Disclosures About Market Risk . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Financial Statements and Supplementary Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Changes in and Disagreements with Accountants on Accounting and Financial Disclosure . . . . . . . . . . . . . . . Controls and Procedures. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Other Information. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Management’s Report on Internal Control over Financial Reporting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Report of Independent Registered Public Accounting Firm . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Part III 10 11 12 13 14 Directors and Executive Officers of the Registrant . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Executive Compensation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Security Ownership of Certain Beneficial Owners and Management . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Certain Relationships and Related Transactions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Principal Accountant Fees and Services. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Page 3 7 10 10 10 10 10 13 15 23 24 24 24 24 25 26 27 27 27 27 27 Part IV 15 Exhibits and Financial Statement Schedules . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28 Corporate Officers, located on page 8 of the company’s printed Annual Report, can be found at the end of the electronic filing of this Form 10-K. Part I Item 1. Business General Owens & Minor, Inc. and subsidiaries (we, us or our), a Fortune 500 company headquartered in Richmond, Virginia, is a leading healthcare logistics company that connects the world of medical products to the point of care. We provide vital supply chain assistance to the providers of healthcare services and the manufacturers of healthcare products, supplies and devices in the United States and Europe. We serve our customers with a service portfolio that covers procurement, inventory management, delivery and sourcing for the healthcare market. With fully developed networks in the United States and Europe, we are equipped to serve a customer base ranging from hospitals, integrated healthcare systems, group purchasing organizations, and the U.S. federal government, to manufacturers of life-science and medical devices and supplies, including pharmaceuticals in Europe. The description of our business should be read in conjunction with the consolidated financial statements and supplementary data included in this Form 10-K. Founded in 1882, Owens & Minor was incorporated in 1926 in Richmond, Virginia. We focus our operations on healthcare logistics services and provide our customers with a service portfolio that covers procurement, inventory management, delivery and sourcing for the healthcare market. Through organic growth and acquisitions over many years, we significantly expanded and strengthened our company, achieving national scale in the United States healthcare market. On August 31, 2012, we acquired the Movianto Group (Movianto), an established European healthcare third-party logistics provider. As a result of the acquisition, we have entered into third-party logistics services for the pharmaceutical, biotechnology and medical device industries in the European market, leveraging an existing platform that also expands our ability to serve our United States-based manufacturer customers on an international level. Our Domestic segment includes all functions in the United States relating to our role as a healthcare services company providing distribution and logistics services to healthcare providers and manufacturers. The International segment consists of Movianto, our European third-party logistics service. Financial information by segment and geographic area beginning with the acquisition of Movianto in 2012 appears in Note 20, “Segment Information,” of the Notes to Consolidated Financial Statements included in this annual report. The Domestic Segment The Healthcare Supply Industry in the United States Healthcare supply volumes in the United States are dependent on the rates of utilization of medical/surgical procedures by consumers, which are subject to fluctuation according to the condition of the domestic economy and other factors. Aside from consumer-driven activity, the healthcare supply industry is also experiencing growing demand for advanced logistics services from healthcare providers and manufacturers that are focused on achieving more efficient and cost- effective supply-chain operations. In the United States, healthcare supply distributors contract with group purchasing organizations (GPOs) that negotiate distribution contracts on behalf of their healthcare provider members and also contract directly with healthcare providers and manufacturers for their services. Healthcare providers are increasingly consolidating into larger, more sophisticated networks that are actively seeking reductions in the total cost of delivering healthcare products. These healthcare providers face complex financial challenges, including managing the cost of purchasing, receiving, storing and tracking supplies. Economic trends have also driven significant consolidation within the healthcare supply industry due to the competitive advantages enjoyed by larger organizations. Among these advantages are the ability to serve customers in widespread geographic locations, purchase inventory in large volume, develop technology platforms and decision-support systems and provide expertise to healthcare providers and manufacturers to help reduce supply chain costs. 3 Our Products and Services We offer a comprehensive portfolio of products and services to healthcare providers and manufacturers in the United States. Our portfolio of medical and surgical supplies includes branded products purchased in large volume from manufacturers and our own proprietary MediChoice® private-label products, which are internally sourced through our sourcing joint venture in China or through a select group of manufacturers. We store these items at our distribution centers and provide delivery of these products, along with related services, to healthcare providers around the nation. Most supplies are delivered using a leased fleet and almost all of our delivery personnel are our teammates, ensuring a consistent level of performance and customer service. In situations where they are more cost-effective and timely, we use contract carriers and parcel delivery services. We customize product deliveries, whether the orders are “just-in-time,” “low-unit-of-measure,” pallets, or truckloads. We also customize delivery schedules according to customers’ needs to increase their efficiency in receiving and storing the product. We have deployed automation equipment in low-unit-of-measure picking modules in our larger distribution centers to maximize efficiency, and our distribution center teammates use voice-pick technology to enhance speed and accuracy in certain warehousing processes. We also offer additional services to healthcare providers including supplier management, analytics, inventory management, outsourced resource management, clinical supply management and business process consulting. Our value-add services help providers improve their process for contracting with vendors, purchasing supplies and streamlining inventory. These include our operating room-focused inventory management program that helps healthcare providers manage suture and endo-mechanical inventory, as well as our customizable surgical supply service that includes the assembly and delivery of surgical supplies in procedure-based totes to coincide with the healthcare providers’ surgical schedule. The majority of our distribution arrangements compensate us on a cost-plus percentage basis, under which a negotiated percentage distribution fee is added to the contract cost agreed to by the customer and the supplier. We price our services for certain other activities under an activity-based pricing model. In these cases, pricing depends upon the range, level or complexity of service that we provide to customers, and in some cases we do not take title to the product involved although we maintain certain custodial risks. As a result, this fee-for-service pricing model aligns the fees we charge with the cost of the services provided, which is a component of selling, general and administrative expenses, rather than with the cost of the product, which is a component of cost of goods sold. We offer a variety of programs and services dedicated to providing logistics and marketing solutions to our manufacturer customers as well. These programs and services are designed to help manufacturers increase market share, drive sales growth, or achieve operational efficiencies. Manufacturer programs are generally negotiated on an annual basis and provide for enhanced levels of support that are aligned with the manufacturer’s annual objectives and growth goals. We have contractual arrangements with manufacturers participating in these programs that provide performance-based incentives to us, as well as cash discounts for prompt payment. Program incentives can be earned on a monthly, quarterly or annual basis. All of our services utilize a common infrastructure of distribution centers, equipment, technology, and delivery methods (internal fleet, common carrier or parcel services). We operate a network of 43 distribution centers located throughout the continental United States, which are strategically located to efficiently serve our provider and manufacturer customers. A significant investment in information technology supports the business and efficiently manages growth, including warehouse management systems, customer service and ordering functions, demand forecasting programs, electronic commerce, data warehousing, decision support and supply-chain management, as well as significant enhancements to back office systems and overall technology infrastructure. During 2012, we initiated a three-year, $50 million investment in our information technology infrastructure in the United States designed to achieve operational and data-management efficiencies, improve customer service, and reduce increases in future operating expenses. The International Segment Our Products and Services Our International segment, comprised of Movianto, represented 4.2% of our consolidated net revenues during 2013. Movianto is a European contract logistics service provider to the pharmaceutical, biotechnology and healthcare industry, offering a broad range of supply chain logistics services to manufacturers. Our warehousing and transportation offerings include storage, controlled-substance handling, cold-chain, emergency and export delivery, inventory management and pick & pack services. Our other services include order-to-cash, re-labeling, kitting, packaging, customer service and returns management. 4 Movianto has a network of 20 logistics centers in 11 European countries, including Belgium, Czech Republic, Denmark, France, Germany, Netherlands, Portugal, Slovakia, Spain, Switzerland and the United Kingdom. To serve its clients, Movianto uses a fleet of leased and owned trucks, including cold-chain delivery trucks. The majority of our drivers are Movianto teammates, although contract carriers and parcel services are used in situations where they are more cost-effective and timely. Movianto’s client contracts are generally for three-year terms with rolling automatic one year extension periods. The tendering or competitive bidding process typically takes 12 to 18 months from the initial client request for proposal until becoming operational. Movianto offers significant flexibility to tailor contracts to specific client requirements, and it benefits from the expansion of clients into additional European countries. Pricing may be activity-based, with fees determined by clients’ particular requirements for warehousing, handling and delivery services, or it may be based on buy-sell wholesaler arrangements for product and distribution services. As a part of the Movianto acquisition in 2012, we entered into transition support services agreements with the former owner of Movianto under which it provides certain information technology and support services for terms ranging from six to 24 months. These services were substantially completed at the end of 2013. Our Customers We currently provide distribution, outsourced resource management and/or consulting services to thousands of healthcare provider customers. These customers include multi-facility networks of healthcare providers offering a broad spectrum of healthcare services to a particular market or markets (IHNs) as well as smaller, independent hospitals in the United States. In addition to contracting with healthcare providers at the IHN level and through GPOs, we also contract with other types of healthcare providers including surgery centers, physicians’ practices and smaller networks of hospitals that have joined together to negotiate terms. We have contracts to provide distribution services to the members of a number of national GPOs, including Novation, LLC (Novation), MedAssets Inc. (MedAssets), Premier, Inc. (Premier) and HealthTrust Purchasing Group (HPG). In 2012 and 2013, we renewed the distribution agreements with all four GPOs to continue our status as an authorized distributor for their member healthcare providers and allow us to compete with other authorized distributors for the business of individual members. Below is a summary of these agreements: GPO Year of Renewal Novation MedAssets Premier HPG 2012 2013 2013 2013 Term 5 years* 3 years 3 years 5 years Sales to Members as a % of Consolidated Net Revenue in 2013 33% 24% 21% 9% * Agreement also includes two one-year renewals after the initial term We have our own independent relationships with most of our hospital customers through separate contractual commitments that may or may not be based upon the terms of our agreement with the GPO. As a result, the termination or expiration of an agreement with a particular GPO would not necessarily mean that we would lose the members of such GPO as our customers. Our supplier and manufacturer customers represent the largest and most influential healthcare manufacturers in the industry. We have long-term relationships with these important companies in the healthcare supply chain and have long provided traditional distribution services to them. We currently have relationships with approximately 1,300 of these supplier and manufacturer customers. In the Domestic segment, sales of products supplied by subsidiaries of Covidien Ltd. accounted for approximately 13% of our consolidated net revenue for 2013. Sales of products supplied by Johnson & Johnson Health Care Systems, Inc. were approximately 10% of our consolidated net revenue for 2013. In Europe, we serve a diverse customer base of approximately 600 manufacturer clients, including pharmaceutical, biotechnology and medical device manufacturers. 5  Asset Management In the healthcare supply distribution industry, a significant investment in inventory and accounts receivable is required to meet the rapid delivery requirements of customers and provide high-quality service. As a result, efficient asset management is essential to our profitability. We continually work to refine our processes to optimize inventory and collect accounts receivable. Inventory We are focused in our efforts to optimize inventory and continually consolidate products and collaborate with supply-chain partners on inventory productivity initiatives. When we convert large-scale, multi-state IHN customers to our distribution network, an additional investment in inventory in advance of expected sales is generally required. We actively monitor inventory for obsolescence and use inventory turnover and other operational metrics to measure our performance in managing inventory. Accounts Receivable In the normal course of business, we provide credit to our domestic and European customers and use credit management techniques to evaluate customers’ creditworthiness and facilitate collection. These techniques may include performing initial and ongoing credit evaluations of customers based primarily on financial information provided by them and from sources available to the general public. We also use third-party information from sources such as credit reporting agencies, banks and other credit references. We actively manage our accounts receivable to minimize credit risk, days sales outstanding (DSO) and accounts receivable carrying costs. Our ability to accurately invoice and ship product to customers enhances our collection results and drives our positive DSO performance. We also have arrangements with certain customers under which they make deposits on account, either because they do not meet our standards for creditworthiness or in order to obtain more favorable pricing. Competition The medical/surgical supply distribution and healthcare logistics industries are highly competitive in the United States and Europe. The U.S. sector includes Owens & Minor, Inc., as well as two major nationwide manufacturers who also provide distribution services, Cardinal Health, Inc. and privately-held Medline, Inc. In addition, we compete with a number of regional and local distributors and customer self-distribution models. Major logistics competitors serving healthcare manufacturers in the United States and in Europe include United Parcel Service, FedEx Corporation, Deutsche Post DHL and Alloga, as well as local competitors in specific countries. Regulation The medical/surgical supply distribution industry in the United States is subject to regulation by federal, state and local government agencies. Each of our distribution centers is licensed to distribute medical and surgical supplies, as well as certain pharmaceutical and related products. We must comply with laws and regulations, including those governing operations, storage, transportation, safety and security standards for each of our distribution centers, of the Food and Drug Administration, the Drug Enforcement Agency, the Department of Transportation, the Department of Homeland Security, the Occupational Safety and Health Administration, and state boards of pharmacy, or similar state licensing boards and regulatory agencies. We are also subject to various federal and state laws intended to protect the privacy of health or other personal information and to prevent healthcare fraud and abuse. We believe we are in material compliance with all statutes and regulations applicable to distributors of medical and surgical supply products and pharmaceutical and related products, including the Healthcare Insurance Portability and Accountability Act of 1996 (HIPAA), Medicare, Medicaid, as well as applicable general employment and employee health and safety laws and regulations. Movianto is subject to local, country and European-wide regulations, including those promulgated by the European Medicines Agency (EMA), a decentralized agency of the European Union responsible for the scientific evaluation of medicines developed by pharmaceutical companies for use in the European Union. In addition, quality requirements are imposed by healthcare industry manufacturers which audit Movianto on a regular basis. Each of our logistics centers in Europe is licensed to distribute medical and surgical supplies, as well as certain pharmaceutical and related products, according to the country- specific requirements. We believe we are in material compliance with all statutes and regulations, including Good Distribution Practices sponsored by the European Commission. Movianto is also ISO 9001:2008 certified across the entire enterprise. 6  Employees At the end of 2013, we employed approximately 4,900 full- and part-time teammates in the Domestic segment and 1,800 in the International segment. Most of our international teammates are covered by collective bargaining agreements. Ongoing teammate training is critical to performance and we use Owens & Minor University®, an in-house training facility, to offer classes in leadership, management development, finance, operations, safety and sales. We continue to have positive relationships with teammates and European works councils. Available Information We make our Forms 10-K, Forms 10-Q and Forms 8-K (and all amendments to these reports) available free of charge through the SEC Filings link in the Investor Relations content section on our website located at www.owens-minor.com as soon as reasonably practicable after they are filed with or furnished to the SEC. Information included on our website is not incorporated by reference into this Annual Report on Form 10-K. You may read and copy any materials we file with the SEC at the SEC’s Public Reference Room at 100 F Street, NE, Washington, DC 20549. You may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC also maintains an Internet site that contains reports, proxy and information statements, and other information regarding the company (http://www.sec.gov). Additionally, we have adopted a written Code of Honor that applies to all of our directors, officers and teammates, including our principal executive officer and senior financial officers. This Code of Honor (including any amendments to or waivers of a provision thereof) and our Corporate Governance Guidelines are available on our website at www.owens- minor.com. Item 1A. Risk Factors Set forth below are certain risk factors that we currently believe could materially and adversely affect our business, financial condition and prospects. These risk factors are in addition to those mentioned in other parts of this report and are not all of the risks that we face. We could also be affected by risks that we currently are not aware of or that we currently do not consider material to our business. Competition The medical/surgical supply distribution industry in the United States is highly competitive and characterized by intense pricing pressure. We compete with other national distributors and a number of regional and local distributors, as well as customer self-distribution models and, to a lesser extent, certain third-party logistics companies. Competitive factors within the medical/surgical supply distribution industry include market pricing, total delivered product cost, product availability, the ability to fill and invoice orders accurately, delivery time, range of services provided, efficient product sourcing, inventory management, information technology, electronic commerce capabilities, and the ability to meet customer-specific requirements. Our success is dependent on the ability to compete on the above factors, while managing internal costs and expenses. These competitive pressures could have a material adverse effect on our results of operations. In addition, in recent years, the healthcare industry in the United States has experienced and continues to experience significant consolidation in response to cost containment legislation and general market pressures to reduce costs. This consolidation of our customers and suppliers generally gives them greater bargaining power to reduce the pricing available to them, which may adversely impact our results of operations. The healthcare third-party logistics business in both the United States and abroad also is characterized by intense competition from a number of international, regional and local companies, including large conventional logistics companies that are moving into the healthcare and pharmaceutical distribution business. This competitive market places continuous pricing pressure on us from customers and manufacturers that could adversely affect our results of operations and financial condition if we are unable to continue to increase our revenues and to offset margin reductions caused by pricing pressures through cost control measures. Dependence on Significant Healthcare Provider Customers In 2013, our top ten customers in the United States represented approximately 23% of our consolidated net revenue. In addition, in 2013, approximately 77% of our consolidated net revenue was from sales to member hospitals under contract with our largest group purchasing organizations (GPO): Novation, MedAssets and Premier. We could lose a significant customer or GPO relationship if an existing contract expires without being replaced or is terminated by the customer or GPO prior to its 7 expiration (if permitted by the applicable contract). Although the termination of our relationship with a given GPO would not necessarily result in the loss of all of the member hospitals as customers, any such termination of a GPO relationship, or a significant individual customer relationship, could have a material adverse effect on our results of operations. Dependence on Significant Domestic Suppliers In the United States, we distribute products from nearly 1,300 suppliers and are dependent on these suppliers for the continuing supply of products. In 2013, sales of products of our ten largest domestic suppliers accounted for approximately 53% of consolidated net revenue. We rely on suppliers to provide agreeable purchasing and delivery terms and performance incentives. Our ability to sustain adequate operating earnings has been, and will continue to be, partially dependent upon our ability to obtain favorable terms and incentives from suppliers, as well as suppliers continuing use of third-party distributors to sell and deliver their products. A change in terms by a significant supplier, or the decision of such a supplier to distribute its products directly to healthcare providers rather than through third-party distributors, could have a material adverse effect on our results of operations. Integration of Acquisitions In connection with our growth strategy, we from time to time acquire other businesses that we believe will expand or complement our existing businesses and operations. In 2012, we completed our first international acquisition through our purchase of Movianto, which has facilities in 11 European countries and operates throughout the European marketplace. The integration of acquisitions, particularly international acquisitions, involves a number of significant risks, which may include but are not limited to, the following: • Expenses and difficulties in the transition and integration of operations and systems; • Retention of current customers and the ability to obtain new customers; • The assimilation and retention of personnel, including management personnel, in the acquired businesses; • Accounting, tax, regulatory and compliance issues that could arise; • Difficulties in implementing uniform controls, procedures and policies in our acquired companies, or in remediating control deficiencies in acquired companies not formerly subject to the Sarbanes-Oxley Act of 2002; • Unanticipated expenses incurred or charges to earnings based on unknown circumstances or liabilities; • • General economic conditions in the markets in which the acquired businesses operate; and • Difficulties encountered in conducting business in markets where we have limited experience and expertise. Failure to realize the synergies and other benefits we expect from the acquisition at the pace we anticipate; If we are unable to successfully complete and integrate our strategic acquisitions in a timely manner, our business, growth strategies and results of operations could be adversely affected. International Operations Our acquisition of Movianto represents our first significant movement into the international marketplace. Additionally, in 2011, we entered into a joint venture in China to provide product sourcing services. Operations outside the United States involve issues and risks, including but not limited to the following, any of which could have an adverse effect on our business and results of operations: • Lack of familiarity with and expertise in conducting business in foreign markets; • • Unexpected changes in foreign regulations or conditions relating to labor, economic or political environment, and Foreign currency fluctuations and exchange risk; social norms or requirements; • Adverse tax consequences and difficulties in repatriating cash generated or held abroad; • Local economic environments, such as in the European markets served by Movianto, including recession, inflation, indebtedness, currency volatility and competition; and • Changes in trade protection laws and other laws affecting trade and investment, including import/export regulations in both the United States and foreign countries. International operations are also subject to risks of violation of laws that prohibit improper payments to and bribery of government officials and other individuals and organizations for the purpose of obtaining or retaining business. These laws include the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act and other similar laws and regulations in foreign jurisdictions, any violation of which could result in substantial liability and a loss of reputation in the marketplace. Failure to comply with these laws also could subject us to civil and criminal penalties that could adversely affect our business and results of operations. 8 Changes in the Healthcare Environment in the United States We, along with our customers and suppliers, are subject to extensive federal and state regulations relating to healthcare as well as the policies and practices of the private healthcare insurance industry. In recent years, there have been a number of government and private initiatives to reduce healthcare costs and government spending. These changes have included an increased reliance on managed care; reductions in Medicare and Medicaid reimbursement levels; consolidation of competitors, suppliers and customers; a shift in healthcare provider venues from acute care settings to clinics, physician offices and home care; and the development of larger, more sophisticated purchasing groups. All of these changes place additional financial pressure on healthcare provider customers, who in turn seek to reduce the costs and pricing of products and services provided by us. We expect the healthcare industry to continue to change significantly and these potential changes, which may include a reduction in government support of healthcare services, adverse changes in legislation or regulations, and further reductions in healthcare reimbursement practices, could have a material adverse effect on our results of operations. In March 2010, federal healthcare legislation known as the Affordable Care Act was enacted. This healthcare reform legislation includes, among other things, provisions for expanded Medicaid eligibility and access to healthcare insurance as well as increased taxes and fees on certain corporations and medical products. Effective January 1, 2013, the Affordable Care Act imposed a 2.3% federal excise tax on manufacturers for sales of certain medical devices. In the event these manufacturers attempt to pass all or a portion of this excise tax through to us, or in the event such tax leads manufacturers to offer less favorable terms and incentives to distributors, our profitability could be adversely impacted. The provisions of the Affordable Care Act will not be fully implemented until 2018 and, although there is no way to predict the full impact of the law on the healthcare industry and our operations, its implementation may have an adverse effect on both customer purchasing and payment behavior and supplier product prices and terms of sale, all of which could adversely affect our results of operations. Regulatory Requirements We must comply with numerous laws and regulations in the United States, Europe, Asia and other countries where we distribute. We also are required to hold permits and licenses and to comply with the operational and security standards of various governmental bodies and agencies. Any failure to comply with these laws and regulations or any failure to maintain the necessary permits, licenses or approvals, or to comply with the required standards, could disrupt our operations and/or adversely affect our results of operations and financial condition. In addition, we are subject to various federal and state laws intended to prevent healthcare fraud and abuse. The requirements of these fraud and abuse laws are complicated and subject to interpretation and may be applied by a regulator, prosecutor or judge in a manner that could negatively impact us financially or operationally. General Economic Climate The financial and economic climate in recent years continues to have a negative impact on most sectors of the domestic economy and the international markets in which Movianto operates. This uncertain financial and economic climate has reduced patient demand for healthcare services, reduced product price inflation, intensified pressures on healthcare providers to reduce both costs and purchases of our products and services and could compromise our customers’ ability to timely pay for their purchases. Poor economic conditions could lead our suppliers to offer less favorable terms of purchase to distributors, which would negatively affect our profitability. These and other possible consequences of financial and economic changes could materially and adversely affect our business and results of operations. Bankruptcy, Insolvency or other Credit Failure of Customers We provide credit in the normal course of business to customers. We perform initial and ongoing credit evaluations of customers and maintain reserves for credit losses. The bankruptcy, insolvency or other credit failure of one or more customers with substantial balances due to us could have a material adverse effect on our results of operations. Reliance on Information Systems and Technological Advancement We rely on information systems to receive, process, analyze and manage data in distributing thousands of inventory items to customers from numerous distribution and logistics centers. These systems are also relied upon for billings to and collections from customers, as well as the purchase of and payment for inventory and related transactions from our suppliers. In addition, the success of our long-term growth strategy is dependent upon the ability to continually monitor and upgrade our information systems to provide better service to customers. Our business and results of operations may be materially adversely affected if systems are interrupted or damaged by unforeseen events (including cyber attacks) or fail to operate for an extended period of time, or if we fail to appropriately enhance our systems to support growth and strategic initiatives. 9 Changes in Tax Laws We operate throughout the United States and Europe as well as in China. As a result, we are subjected to the tax laws and regulations of the United States federal, state and local governments and of various foreign jurisdictions. From time to time, legislative and regulatory initiatives are proposed, including but not limited to proposals to repeal LIFO (last-in, first-out) treatment of domestic inventory or changes in tax accounting methods for inventory or other tax items, that could adversely affect our tax positions, tax rate or cash payments for taxes. Item 1B. Unresolved Staff Comments None. Item 2. Properties Our Domestic segment had 43 distribution centers as well as office and warehouse space across the United States as of December 31, 2013. We lease all of these distribution centers from unaffiliated third parties. We also lease offices in China and Malaysia as well as small offices for sales and consulting personnel across the United States. In addition, we have a warehousing arrangement in Honolulu, Hawaii, with an unaffiliated third party, and lease space on a temporary basis from time to time to meet our inventory storage needs. We own our corporate headquarters building, and adjacent acreage, in Mechanicsville, Virginia, a suburb of Richmond, Virginia. Our International segment leases18 and owns two logistics centers across 11 European countries. We also operate seven transport depots, of which we lease six and own one. We also lease office space in Stuttgart, Germany. We regularly assess our business needs and make changes to the capacity and location of distribution and logistics centers. We believe that our facilities are adequate to carry on our business as currently conducted. A number of leases are scheduled to terminate within the next several years. We believe that, if necessary, we could find facilities to replace these leased premises without suffering a material adverse effect on our business. Item 3. Legal Proceedings We are subject to various legal actions that are ordinary and incidental to our business, including contract disputes, employment, workers’ compensation, product liability, regulatory and other matters. We establish reserves from time to time based upon periodic assessment of the potential outcomes of pending matters. In addition, we believe that any potential liability arising from employment, product liability, workers’ compensation and other personal injury litigation matters would be adequately covered by our insurance coverage, subject to policy limits, applicable deductibles and insurer solvency. While the outcome of legal actions cannot be predicted with certainty, we believe, based on current knowledge and the advice of counsel, that the outcome of these currently pending matters, individually or in the aggregate, will not have a material adverse effect on our financial condition or results of operations. Part II Item 4. Mine Safety Disclosures Not applicable. Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities Owens & Minor, Inc.’s common stock trades on the New York Stock Exchange under the symbol OMI. As of February 13, 2014, there were approximately 3,484 common shareholders of record. We believe there are an estimated additional 30,985 beneficial holders of our common stock. See Selected Quarterly Financial Information in Item 15 of this report for high and low closing sales prices of our common stock and quarterly cash dividends per common share and Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations, for a discussion of our dividend payments. 10 5-Year Total Shareholder Return The following performance graph compares the performance of our common stock to the S&P 500 Index and an Industry Peer Group (which includes the companies listed below) for the last five years. This graph assumes that the value of the investment in the common stock and each index was $100 on December 31, 2008, and that all dividends were reinvested. The Industry Peer Group, weighted by market capitalization, consists of companies engaged in the business of healthcare product distribution. The Peer Group includes pharmaceutical distribution companies: AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation; and medical product distribution companies: Henry Schein, Inc., and Patterson Companies, Inc. Company Name / Index Owens & Minor, Inc. S&P 500 Index Peer Group Base Period 12/2008 12/2009 12/2010 12/2011 12/2012 12/2013 Years Ended $ 100.00 $ 116.81 $ 123.13 $ 119.43 $ 126.30 $ 100.00 100.00 126.46 146.87 145.51 174.80 148.59 190.01 172.37 223.72 166.60 228.19 359.71 Share Repurchase Program. In February 2011, our Board of Directors authorized a share repurchase program of up to $50 million of our outstanding common stock to be executed at the discretion of management over a three-year period, expiring in February 2014. The program is intended to offset shares issued in conjunction with our stock incentive plan and may be suspended or discontinued at any time. During the year ended December 31, 2013, we repurchased in open-market transactions and retired 560 thousand shares at an average price per share of $33.72. As of December 31, 2013, we have no remaining shares authorized for repurchase. In February 2014, our Board of Directors renewed our share repurchase program authorizing the purchase of $100 million in common stock through 2017. The timing of repurchases and the number of shares of common stock to be repurchased will be determined by management based upon market conditions and other factors. The program is intended, in part, to offset shares issued in conjunction with our stock incentive plan and may be suspended or discontinued at any time. 11 The following table summarizes the share repurchase activity by month during the fourth quarter of 2013. Period October 2013 November 2013 December 2013 Total Total number of shares purchased Average price paid per share Total number of shares purchased as part of a publicly announced program Maximum dollar value of shares that may yet be purchased under the program $ $ $ 41,600 21,200 25,770 88,570 34.58 36.88 37.09 $ $ $ 41,600 21,200 25,770 88,570 1,737,703 955,593 — 12 Item 6. Selected Consolidated Financial Data (in thousands, except ratios and per share data) Summary of Operations: Net revenue (9) Income from continuing operations Loss from discontinued operations, net of tax(1) Net income Per Common Share(6) : Net income (loss) attributable to Owens & Minor, Inc. per common share—basic: Continuing operations Discontinued operations Net income per share—basic Net income (loss) attributable to Owens & Minor, Inc. per common share—diluted: Continuing operations Discontinued operations Net income per share—diluted Cash dividends Stock price at year end Summary of Financial Position: Total assets Cash and cash equivalents Total debt Total Owens & Minor, Inc. shareholders’ equity Selected Ratios: Gross margin as a percent of revenue Selling, general, and administrative expenses as a percent of revenue Operating earnings as a percent of revenue Days sales outstanding (DSO) (7) Average annual inventory turnover (8) At or for the Year Ended December 31, 2013 (2) 2012 (3) 2011 (4) 2010 (5) 2009 $9,071,532 $ 8,868,324 $ 8,627,912 $ 8,123,608 $ 8,037,624 $ 110,882 $ 109,003 $ 115,198 $ 110,579 $ 116,859 — $ 110,882 — — — $ 109,003 $ 115,198 $ 110,579 $ (12,201) 104,658 $ $ $ $ $ $ 1.76 — 1.76 1.76 — 1.76 0.960 36.56 $ $ $ $ $ $ 1.72 — 1.72 1.72 — 1.72 0.880 28.51 $ $ $ $ $ $ 1.82 — 1.82 1.81 — 1.81 0.800 27.79 $ $ $ $ $ $ 1.76 — 1.76 1.75 — 1.75 0.708 29.43 $ $ $ $ $ $ 1.87 (0.19) 1.68 1.86 (0.19) 1.67 0.613 28.62 $2,324,042 $ 2,214,398 $ 1,946,815 $ 1,822,039 $ 1,747,088 $ 101,905 $ 216,243 $1,023,913 $ $ $ 97,888 217,591 972,526 $ $ $ 135,938 214,556 918,087 $ $ $ 159,213 210,906 857,518 $ $ $ 96,136 210,917 769,179 12.31% 10.43% 9.94% 9.94% 10.13% 9.52% 2.18% 22.1 10.4 7.70% 2.22% 20.8 10.1 7.08% 2.36% 20.7 10.2 6.94% 2.41% 19.6 10.4 7.37% 2.50% 21.4 10.6 (1) (2) (3) (4) In January 2009, we exited our direct-to-consumer diabetes supply (DTC) business. Accordingly, the DTC business is presented as discontinued operations for all periods presented. We incurred charges of $12.4 million ($8.9 million after tax, or $0.14 per common share) associated with acquisition-related and exit and realignment activities in 2013. See Notes 3 and 9 of Notes to Consolidated Financial Statements. We incurred charges of $10.2 million ($8.2 million after tax, or $0.13 per common share) associated with acquisition-related and exit and realignment activities in 2012. See Notes 3 and 9 of Notes to Consolidated Financial Statements. We incurred charges of $13.2 million ($8.0 million after tax, or $0.13 per common share) associated with acquisition-related and exit and realignment activities in 2011. See Note 9 of Notes to Consolidated Financial Statements. 13 (5) (6) (7) (8) (9) We terminated our frozen defined benefit pension plan in the fourth quarter of 2010 and recognized a settlement charge of $19.6 million ($11.9 million after tax, or $0.19 per common share). On March 31, 2010, we effected a three-for-two stock split of our outstanding shares of common stock in the form of a stock dividend of one share of common stock for every two shares outstanding to stockholders of record on March 15, 2010. The common stock began trading on a post-split basis on April 1, 2010. All share and per-share data (except par value) have been adjusted to reflect this split. Based on net revenue for the fourth quarter of the year. Based on cost of goods sold for the preceding 12 months. 2012 net revenue has been revised to reflect current year revenue presentation. See Note 1 of Notes to Consolidated Financial Statements. 14 Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations Management’s discussion and analysis of financial condition and results of operations is intended to assist the reader in the understanding and assessment of significant changes and trends related to the results of operations of the Company together with its subsidiaries. The discussion and analysis presented below refers to, and should be read in conjunction with, the consolidated financial statements and accompanying notes included in Item 8 of Part II of this Annual Report on Form 10-K. Overview Owens & Minor, Inc., along with its subsidiaries, (we, us, or our) is a leading national distributor of name-brand medical and surgical supplies and a healthcare logistics company. We report our business under two segments: Domestic and International. The Domestic segment includes all services in the United States relating to our role as a medical supply logistics company serving healthcare providers and manufacturers. The International segment, which is comprised of the Movianto Group (Movianto) acquired on August 31, 2012, provides third-party logistics for the pharmaceutical, biotechnology and medical device industries in the European market. Segment financial information is provided in Note 20 of Notes to the Consolidated Financial Statements included in this annual report. Financial Highlights. The following table provides a reconciliation of reported operating earnings, net income and diluted net income per common share to non-GAAP measures used by management: (Dollars in thousands, except per share data) Operating earnings, as reported (GAAP) Acquisition-related and exit and realignment charges Operating earnings, adjusted (non-GAAP) (Adjusted Operated Earnings) Adjusted Operating Earnings as a percent of revenue (non-GAAP) Net income attributable to Owens & Minor, Inc., as reported (GAAP) Acquisition-related and exit and realignment charges, net of tax Net income, adjusted (non-GAAP) (Adjusted Net Income) Net income attributable to Owens & Minor, Inc. per diluted common share, as reported (GAAP) Acquisition-related and exit and realignment charges, per diluted common share Net income per diluted common share, adjusted (non-GAAP) (Adjusted EPS) For the years ended December 31, 2013 198,083 12,444 210,527 2.32% 110,882 8,856 119,738 1.76 0.14 $ $ $ $ $ 2012 196,753 10,164 206,917 2.33% 109,003 8,200 117,203 1.72 0.13 $ $ $ $ $ 1.90 $ 1.85 $ $ $ $ $ $ $ 2011 203,515 13,168 216,683 2.51% 115,198 7,993 123,191 1.81 0.13 1.94 Use of Non-GAAP Measures Our management’s discussion and analysis contains financial measures that are not calculated in accordance with U.S. generally accepted accounting principles (GAAP). In general, the measures exclude items and charges that (i) management does not believe reflect our core business and relate more to strategic, multi-year corporate activities; or (ii) relate to activities or actions that may have occurred over multiple or in prior periods without predictable trends. Management uses these non-GAAP financial measures internally to evaluate our performance, evaluate the balance sheet, engage in financial and operational planning and determine incentive compensation. Management provides these non-GAAP financial measures to investors as supplemental metrics to assist readers in assessing the effects of items and events on our financial and operating results and in comparing our performance to that of our competitors. However, the non-GAAP financial measures used by us may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies. The non-GAAP financial measures disclosed by us should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP. 15 Acquisition-related charges, pre-tax, of $3.5 million and $10.5 million in 2013 and 2012 are associated with Movianto and $0.5 million in 2011 is related to the establishment of our joint venture in China. Acquisition-related charges in 2013 primarily consist of costs to transition Movianto's information technology and other operations and administrative functions from the former owner. Charges in 2012 are primarily transaction costs incurred to perform due diligence and to analyze, negotiate and consummate the acquisition and costs to perform post-closing activities to establish a tax-efficient organizational structure. Exit and realignment charges (income), pre-tax, of $8.9 million, $(0.4) million and $12.7 million in 2013, 2012 and 2011 are associated with optimizing our operations and include the consolidation of distribution and logistics centers and closure of offsite warehouses in the United States and Europe. Net of tax charges have been tax effected in the preceding table using a blended income tax rate depending on the amount of charges incurred in different tax jurisdictions. Unless otherwise stated, our analysis hereinafter excludes acquisition-related and exit and realignment charges. More information about these charges is provided in Notes 3 and 9 of Notes to Consolidated Financial Statements included in this annual report. Adjusted EPS increased to $1.90 in 2013 from $1.85 in 2012 primarily due to an increase in Adjusted Operating Earnings of $3.6 million. Domestic segment operating earnings were $211.9 million for 2013, a decrease of $0.4 million when compared to the prior year. International segment operating losses improved over the prior year by $4.0 million to $1.4 million for 2013. The Domestic segment operating earnings were affected by higher gross margin, which was fully offset by higher selling, general and administrative expenses. The International segment operating loss includes a full year of activity which showed improving results in the second half of 2013. Results of Operations 2013 compared to 2012 Net revenue. (Dollars in thousands) Domestic International Net revenue For the years ended December 31, 2013 2012 $ 8,688,018 $ 8,731,484 383,514 136,840 $ 9,071,532 $ 8,868,324 $ $ Change $ (43,466) 246,674 203,208 % (0.5)% 180.3 % 2.3 % Net revenue for the current year increased due to a full year of activity in our International segment compared to four months in the prior year. Domestic segment revenue continued to be impacted by ongoing market trends including lower rates of healthcare utilization. In addition, our continued rationalization of smaller, less profitable healthcare provider customers and suppliers and reduced government purchases were not fully offset by growth in existing customers, fee-for- service and new business. Fee-for-service business represents approximately two-thirds of net revenue in the International segment. Gross margin. (Dollars in thousands) Gross margin As a % of net revenue For the years ended December 31, 2013 2012 $ 1,117,075 $ 924,654 $ 12.31% 10.43% Change $ 192,421 % 20.8% Gross margin increased primarily due to a full year of Movianto activity in the current year which contributed $177.4 million to the year over year change. The Domestic segment gross margin benefitted from strategic initiatives including growth in fee-for-service business during the year and supplier price changes in the first and second quarters of 2013 at a higher level than in 2012. 16 We value Domestic segment inventory under the LIFO method. Had inventory been valued under the first-in, first- out (FIFO) method, gross margin as a percentage of net revenue would have been lower by 3 basis points in 2013 and higher by 5 basis points in 2012. Operating expenses. (Dollars in thousands) SG&A expenses As a % of net revenue Depreciation and amortization Other operating income, net For the years ended December 31, 2013 863,656 9.52% 50,586 (7,694) $ $ $ 2012 682,595 7.70% 39,604 (4,462) $ $ $ $ $ $ Change $ % 181,061 26.5% 10,982 (3,232) 27.7% 72.4% Selling, general and administrative (SG&A) expenses include labor, warehousing, handling and delivery costs associated with our distribution and logistics services, as well as labor costs for our supply-chain consulting services and all costs associated with our fee-for-service business. The costs to convert new customers to our information systems are generally incurred prior to the recognition of revenues from new customers. The International segment also includes costs for information technology and other transition services provided by the former owners of Movianto which were substantially completed in 2013. SG&A expense increased by $165.4 million in the current year due to a full year of activity in Movianto. Domestic SG&A expense also increased over the prior year due to greater fee-for-service sales activity, increased costs to support strategic initiatives and higher costs associated with workers' compensation, litigation and healthcare. During the second quarter of 2013, we reached a settlement in the administrative proceedings before the California Board of Equalization related to certain municipal sales tax incentives. As a result, SG&A expenses were reduced in 2013 by a net amount of $4.3 million, which was fully offset by the increased costs noted above. In the future, the company expects to receive an ongoing tax incentive that will vary with eligible revenues generated by sales to California-based customers. More information about this incentive is provided in Note 18 of Notes to Consolidated Financial Statements included in this annual report. Depreciation and amortization expense increase in the current year was primarily related to warehouse equipment and information technology hardware and software acquired with Movianto. In addition, depreciation and amortization increased $0.8 million in the Domestic segment due to software enhancements for operational efficiency improvements. Other operating income includes finance charge income of $6.0 million and $4.9 million in 2013 and 2012. The increase over the prior year was due to $1.6 million increase in income associated with product financing arrangements with customers in Europe, $0.8 million in foreign exchange gains and a net $0.9 million in Domestic charges incurred in 2012 associated with specific litigation matters and loss contingency expenses which did not recur in the current year. Interest expense, net. (Dollars in thousands) Interest expense, net Effective interest rate For the years ended December 31, 2013 13,098 $ 2012 13,397 $ 6.05% 6.17% Change $ % $ (299) (2.2)% For 2013, the decrease in interest expense was primarily from lower commitment fees in our new revolving credit facility effective June 2012, partially offset by less interest income earned on cash and cash equivalents. Income taxes. (Dollars in thousands) Income tax provision Effective tax rate For the years ended December 31, 2013 2012 Change $ % $ 74,103 $ 74,353 $ (250) (0.3)% 40.1% 40.6% The provision for income taxes, including income taxes on acquisition-related and exit and realignment charges, decreased from the prior year due to the impact of non-deductible acquisition-related costs in 2012 incurred as a result of the Movianto acquisition as well as results of benefits recognized in the current year upon the conclusion of examinations of our 2009 and 2010 Federal and certain state income tax returns. These benefits were partially offset by the impact of foreign taxes. 17 2012 compared to 2011 Net revenue. (Dollars in thousands) Domestic International Net revenue For the years ended December 31, 2012 2011 $ 8,731,484 $ 8,627,912 136,840 — $ 8,868,324 $ 8,627,912 $ $ Change $ 103,572 136,840 240,412 % 1.2% N/A 2.8% Domestic segment revenue increased as a result of growth from existing customers. Factors affecting the Domestic segment growth rate included lower comparative utilization of healthcare services, reduced product price inflation and a lower level of government purchasing, as well as ongoing rationalization of certain of the company’s suppliers. The International segment revenue for 2012 includes activity since our acquisition on August 31, 2012. Gross margin. (Dollars in thousands) Gross margin As a % of net revenue For the years ended December 31, 2012 2011 $ 924,654 $ 857,537 $ 10.43% 9.94% Change $ 67,117 % 7.8% The increases in gross margin dollars and gross margin percentage are primarily due to contributions by Movianto for the four months since acquisition. These gains were partially offset by declines in the Domestic segment due to customer mix, including lower margin on new contracts with large integrated health networks and competitive pressures. We value Domestic segment inventory under the LIFO method. Had inventory been valued under the first-in, first- out (FIFO) method, gross margin as a percentage of net revenue would have been higher by 5 basis points in 2012 and 16 basis points in 2011. Operating expenses. (Dollars in thousands) SG&A expenses As a % of net revenue Depreciation and amortization Other operating income, net For the years ended December 31, Change 2012 $ 682,595 7.70% $ $ 39,604 (4,462) $ $ $ 2011 610,657 7.08% 34,135 (3,938) $ $ $ $ 71,938 5,469 (524) % 11.8 % 16.0 % 13.3 % SG&A expenses include labor, warehousing, handling and delivery costs associated with our distribution and third- party logistics services, as well as labor costs for our supply-chain consulting services. The costs to convert new customers to our information systems are generally incurred prior to the recognition of revenues. SG&A expenses increased as a result of the acquisition of Movianto. The increase was partially offset by decreases in the Domestic segment primarily due to lower expenses in our fee-for-service operations, including lower costs for our third- party logistics business that converted a large new customer during 2011. International segment SG&A expenses include costs for information technology and other transition services provided by the former owners of Movianto, as well as information technology outsourcing and consulting for support and maintenance of its information systems. Depreciation and amortization, primarily related to warehouse equipment and information technology hardware and software, increased in 2012 as a result of the acquisition of Movianto. Domestic segment depreciation and amortization increased $2.4 million for operational software improvements and for warehouse equipment and leasehold improvements related to warehouse automation and the relocation of a distribution center. This increase was partially offset by lower amortization resulting from the expiration of noncompete agreements. 18 Other operating income, net included finance charge income of $4.9 million and $2.9 million for 2012 and 2011. Finance charge income for 2012 includes income from customer inventory financing arrangements in Europe. Other operating income, net, in 2012 includes legal expenses and loss contingencies expense of approximately $2.0 million associated with California-specific litigation and compensation and benefits requirements, partially offset by income of $1.1 million from the settlement of a class action litigation. Other operating income for 2011 benefitted from $2.2 million received from settlement of an anti-trust class action lawsuit. In addition, other operating income in 2011 included expenses of $1.7 million primarily for the development of a model for partnering with customers. Interest expense, net. (Dollars in thousands) Interest expense, net Effective interest rate For the years ended December 31, 2012 2011 Change $ % $ 13,397 $ 13,682 $ (285) (2.1)% 6.17% 6.42% For 2012, the effective interest rate decreased to 6.17% primarily due to a 30 basis point decrease as a result of replacing our revolving credit facility in June 2012 with a new revolving credit facility with lower commitment fees (refer to Capital Resources in Management’s Discussion and Analysis of Financial Condition for a description of the new revolving credit facility). The decrease in commitment fees was partially offset by a decline in interest income from interest rate swaps, which were terminated in 2011. Income taxes. (Dollars in thousands) Income tax provision Effective tax rate For the years ended December 31, 2012 2011 Change $ % $ 74,353 $ 74,635 $ (282) (0.4)% 40.6% 39.3% Excluding the acquisition-related and exit and realignment costs in 2012, of which approximately $4.6 million were not tax deductible, the effective tax rate was 39.4% for 2012. Financial Condition, Liquidity and Capital Resources Financial condition. We monitor operating working capital through days sales outstanding (DSO) and merchandise inventory turnover. We estimate a hypothetical increase (decrease) in DSO of one day would result in a decrease (increase) in our cash balances, an increase (decrease) in borrowings against our revolving credit facility, or a combination thereof of approximately $25 million. The majority of our cash and cash equivalents are held in cash depository accounts with major banks in the United States and Europe or invested in high-quality, short-term liquid investments. Changes in our working capital can vary in the normal course of business based upon the timing of inventory purchases, collection of accounts receivable, and payment to suppliers. (Dollars in millions) Cash and cash equivalents Accounts and notes receivable, net of allowances Consolidated DSO (1) Merchandise inventories Consolidated inventory turnover (2) Accounts payable For the years ended December 31, 2013 2012 Change $ % $ $ $ $ 101.9 572.9 22.1 771.7 10.4 643.9 $ $ $ $ 97.9 537.3 20.8 763.8 10.1 603.1 $ $ $ $ 4.0 35.6 7.9 40.8 4.1% 6.6% 1.0% 6.8% (1) Based on year end accounts receivable and net revenue for the fourth quarter (2) Based on average annual inventory and costs of goods sold for the years ended December 31, 2013 and 2012 19 Liquidity and capital expenditures. The following table summarizes our consolidated statements of cash flows for the years ended December 31, 2013, 2012 and 2011: (Dollars in millions) Net cash provided by (used for) continuing operations: Operating activities Investing activities Financing activities Discontinued operations Effect of exchange rate changes on cash Increase (decrease) in cash and cash equivalents 2013 2012 2011 $ $ 140.6 (57.1) (82.0) — 2.5 4.0 $ $ 218.5 (190.8) (68.4) — 2.7 (38.0) $ $ 68.4 (33.9) (57.5) (0.3) — (23.3) Cash provided by operating activities was $140.6 million in 2013, compared to $218.5 million in 2012 and $68.4 million in 2011. Cash from operating activities for 2013 decreased compared to 2012 due to changes in working capital, including increases in accounts and notes receivable which experienced an increase in DSO of 1.3 days (unfavorable impact on cash of $33.3 million). Cash from operating activities for 2012 increased over 2011 due to the reduction of Domestic segment inventories and benefitted from a decrease in Domestic segment DSO of 1.6 days in 2012 (favorable impact of approximately $38.3 million). Cash from operating activities in 2011 was a result of operating earnings and an increase in accounts payable, due to increased inventory purchases, offset by a build-up of inventory of approximately $100 million for new business, an increase in DSO of 1.1 days (unfavorable impact on cash of $26.3 million), and an increase in other current assets related to our growth in revenues. Cash used for investing activities was $57.1 million for 2013, compared to $190.8 million for 2012 and $33.9 million for 2011. Capital expenditures in 2013 were $60.1 million primarily related to information technology initiatives and distribution center and logistics facility moves and modifications. In 2012, we acquired Movianto in exchange for approximately $155.2 million of cash plus assumed third-party debt (primarily capitalized leases) of $2.1 million. Domestic segment capital expenditures were $34.5 million in 2012, primarily related to our strategic and operational efficiency initiatives, particularly initiatives relating to information technology enhancements. Capital expenditures in 2011 primarily included leasehold improvements and warehouse equipment for our distribution centers and logistics facilities, as well as investments in operational software improvements and certain customer-facing technologies. Net cash used in financing activities was $82.0 million in 2013, 68.4 million in 2012, and $57.5 million in 2011. We paid dividends of $60.7 million, $55.7 million and $50.9 million and repurchased common stock under a share repurchase program for $18.9 million, $15.0 million and $16.1 million in the years ended December 31, 2013, 2012 and 2011. In addition, in 2011 we received proceeds of $4.0 million as a result of the termination of interest rate swaps. Cash used by operating activities of discontinued operations was $0.3 million for 2011, associated with administrative costs. Capital resources. Our sources of liquidity include cash and cash equivalents and a revolving credit facility. On June 5, 2012, we entered into a five-year $350 million Credit Agreement with Wells Fargo Bank, N.A., JPMorgan Chase Bank, N.A. and a syndicate of financial institutions (the Credit Agreement). This agreement replaced an existing $350 million credit agreement set to expire on June 7, 2013. Under the Credit Agreement, we have the ability to request two one-year extensions and to request an increase in aggregate commitments by up to $150 million. The interest rate, which is subject to adjustment quarterly, is based on the London Interbank Offered Rate (LIBOR), the Federal Funds Rate or the Prime Rate, plus an adjustment based on the better of our debt ratings or leverage ratio (Credit Spread) as defined by the Credit Agreement. We are charged a commitment fee of between 17.5 and 42.5 basis points on the unused portion of the facility. The terms of the Credit Agreement limit the amount of indebtedness that we may incur and require us to maintain ratios for leverage and interest coverage, including on a pro forma basis in the event of an acquisition. At December 31, 2013, we had no borrowings and letters of credit of $5.0 million outstanding on the revolving credit facility, leaving $345.0 million available for borrowing. We may utilize the revolving credit facility for long-term strategic growth, capital expenditures, working capital and general corporate purposes. If we were unable to access the revolving credit facility, it could impact our ability to fund these needs. During 2013, we had no borrowings or repayments under the credit facilities. Based on our leverage ratio at December 31, 2013, the interest rate under the new credit facility was LIBOR plus 1.375%. We have $200 million of senior notes outstanding, which mature in 2016 and bear interest at 6.35%, payable semi-annually on April 15 and October 15. The revolving credit facility and senior notes contain cross-default provisions which could result in the acceleration of payments due in the event of default of either agreement. We believe we were in compliance with the debt covenants at December 31, 2013. 20 We earn a portion of our operating earnings in foreign jurisdictions outside the U.S., which we consider to be indefinitely reinvested. Accordingly, no U.S. federal and state income taxes and withholding taxes have been provided on these earnings. Our cash, cash equivalents, short-term investments, and marketable securities held by our foreign subsidiaries totaled $22.2 million and $24.9 million as of December 31, 2013 and 2012. We do not intend, nor do we foresee a need, to repatriate these funds or other assets held outside the U.S. In the future, should we require more capital to fund discretionary activities in the U.S. than is generated by our domestic operations and is available through our borrowings, we could elect to repatriate cash or other assets from foreign jurisdictions that have previously been considered to be indefinitely reinvested. Upon distribution of these assets, we could be subject to additional U.S. federal and state income taxes and withholding taxes payable to foreign jurisdictions, where applicable. The IRS on January 10, 2014 released final regulations relating to the adjustment of inventory costs for certain sales- based vendor charge-backs and the allowable treatment of these charge-backs in tax LIFO calculations. The Company is currently analyzing the impact of this regulatory change on our tax LIFO position, which could cause our related deferred tax liability to become due and payable, impacting future cash flow. We paid quarterly cash dividends on our outstanding common stock at the rate of $0.24 per share during 2013, $0.22 per share during 2012, and $0.20 per share during 2011. Our annual dividend payout ratio for the three years ended December 31, 2013, based on Adjusted EPS, was in the range of 41.2% to 50.5%. In February 2014, the Board of Directors approved a 4.2% increase in the amount of our quarterly dividend to $0.25 per common share. We anticipate continuing to pay quarterly cash dividends in the future. However, the payment of future dividends remains within the discretion of the Board of Directors and will depend upon our results of operations, financial condition, capital requirements and other factors. In February 2011, the Board of Directors authorized a share repurchase program of up to $50 million of our outstanding common stock to be executed at the discretion of management over a three-year period, expiring in February 2014. The program is intended to offset shares issued in conjunction with our stock incentive plan and may be suspended or discontinued at any time. During 2013, we repurchased approximately 560 thousand shares at $18.9 million under this program. At December 31, 2013, we had purchased all shares authorized under this program. In February 2014, our Board of Directors renewed our share repurchase program authorizing the purchase of $100 million in common stock through 2017. The timing of repurchases and the number of shares of common stock to be repurchased will be determined by management based upon market conditions and other factors. The program is intended to offset shares issued in conjunction with our stock incentive plan and may be suspended or discontinued at any time. We believe available financing sources, including cash generated by operating activities and borrowings under the Credit Agreement, will be sufficient to fund our working capital needs, capital expenditures, long-term strategic growth, payments under long-term debt and lease arrangements, payments of quarterly cash dividends, share repurchases and other cash requirements. While we believe that we will have the ability to meet our financing needs in the foreseeable future, changes in economic conditions may impact (i) the ability of financial institutions to meet their contractual commitments to us, (ii) the ability of our customers and suppliers to meet their obligations to us or (iii) our cost of borrowing. Off-Balance Sheet Arrangements We do not have guarantees or other off-balance sheet financing arrangements, including variable interest entities, which we believe could have a material impact on financial condition or liquidity. Contractual Obligations The following is a summary of our significant contractual obligations as of December 31, 2013: (Dollars in millions) Payments due by period Contractual obligations Long-term debt (1) Purchase obligations (2) Operating leases (2) Capital lease obligations (1) Unrecognized tax benefits, net (3) Other long-term liabilities (4) Total contractual obligations (5) Total Less than 1 year $ 231.8 $ 145.2 296.5 12.8 4.2 80.4 770.9 $ 21 $ 1-3 years 4-5 years $ 219.1 $ — $ 74.6 95.2 5.8 — 30.4 65.1 2.8 — 12.7 40.2 60.1 3.9 — 3.1 120.0 $ 5.4 400.1 $ 4.6 102.9 $ After 5 years — — 76.1 0.3 — 67.3 143.7 (1) (2) (3) (4) (5) See Note 10 of Notes to Consolidated Financial Statements. Debt is assumed to be held to maturity with interest paid at the stated rate in effect at December 31, 2013. See Note 18 of Notes to Consolidated Financial Statements. We cannot reasonably estimate the timing of cash settlement for the liability associated with unrecognized tax benefits. Other long-term liabilities include estimated minimum required payments for our unfunded retirement plan for certain officers. See Note 13 of Notes to Consolidated Financial Statements. Certain long-term liabilities, including deferred tax liabilities and post-retirement benefit obligations, are excluded as we cannot reasonably estimate the timing of payments for these items. Excludes certain contingent contractual obligations that are required to be paid in the event that performance targets specified by customer contracts are not achieved. See Note 18 of Notes to Consolidated Financial Statements. Critical Accounting Policies Our consolidated financial statements and accompanying notes have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of the financial statements requires us to make estimates and assumptions that affect the reported amounts and related disclosures. We continually evaluate the accounting policies and estimates used to prepare the financial statements. Critical accounting policies are defined as those policies that relate to estimates that require us to make assumptions about matters that are highly uncertain at the time the estimate is made and could have a material impact on our results due to changes in the estimate or the use of different assumptions that could reasonably have been used. Our estimates are generally based on historical experience and various other assumptions that are judged to be reasonable in light of the relevant facts and circumstances. Because of the uncertainty inherent in such estimates, actual results may differ. We believe our critical accounting policies and estimates include allowances for losses on accounts and notes receivable, inventory valuation, accounting for goodwill and long-lived assets, self-insurance liabilities, supplier incentives, and business combinations. Allowances for losses on accounts and notes receivable. We maintain valuation allowances based upon the expected collectability of accounts and notes receivable. The allowances include specific amounts for accounts that are likely to be uncollectible, such as customer bankruptcies and disputed amounts, and general allowances for accounts that may become uncollectible. These allowances are estimated based on a number of factors, including industry trends, current economic conditions, creditworthiness of customers, age of the receivables, changes in customer payment patterns, and historical experience. At December 31, 2013, accounts and notes receivable were $573 million, net of allowances of $15.0 million. An unexpected bankruptcy or other adverse change in the financial condition of a customer could result in increases in these allowances, which could have a material effect on the results of operations. Inventory valuation. Merchandise inventories are valued at the lower of cost or market, with cost determined using the last-in, first-out (LIFO) method for Domestic segment inventories and the first-in, first-out (FIFO) method for International segment inventories. An actual valuation of inventory under the LIFO method is made only at the end of the year based on the inventory levels and costs at that time. LIFO calculations are required for interim reporting purposes and are based on estimates of the expected mix of products in year-end inventory. In addition, inventory valuation includes estimates of allowances for obsolescence and variances between actual inventory on-hand and perpetual inventory records that can arise throughout the year. These estimates are based on factors such as the age of inventory and historical trends. At December 31, 2013, the carrying value of inventory was $772 million, which is $109 million lower than the value of inventory had it all been accounted for on a FIFO basis. Goodwill and long-lived assets. Goodwill represents the excess of consideration paid over the fair value of identifiable net assets acquired. Long-lived assets, which are a component of identifiable net assets, include intangible assets with finite useful lives, property and equipment, and computer software costs. Intangible assets with finite useful lives consist primarily of customer relationships and non-compete agreements acquired through business combinations. Certain assumptions and estimates are employed in determining the fair value of identifiable net assets acquired. 22 We evaluate goodwill for impairment annually and whenever events occur or changes in circumstance indicate that the carrying amount of goodwill may not be recoverable. In performing the impairment test, we perform qualitative assessments based on macroeconomic conditions, structural changes in the industry, estimated financial performance, and other relevant information. If necessary, we perform a quantitative analysis to estimate the fair value of the reporting unit using valuation techniques, including comparable multiples of the reporting unit's earnings before interest, taxes, depreciation and amortization (EBITDA) and discounted cash flows. The EBITDA multiples are based on an analysis of current enterprise valuations and recent acquisition prices of similar companies, if available. Goodwill totaled $275 million at December 31, 2013. Long-lived assets, which exclude goodwill, are evaluated for impairment whenever events or changes in circumstances indicate that the carrying amount of long-lived assets may not be recoverable. We assess long-lived assets for potential impairment by comparing the carrying value of an asset, or group of related assets, to its estimated undiscounted future cash flows. At December 31, 2013, long-lived assets included property and equipment of $192 million, net of accumulated depreciation; intangible assets of $40.4 million, net of accumulated amortization; and computer software costs of $74.4 million, net of accumulated amortization. We did not record any material impairment losses related to goodwill or long-lived assets in 2013. However, the impairment review of goodwill and long-lived assets requires the extensive use of accounting judgment, estimates and assumptions. The application of alternative assumptions could produce materially different results. Self-insurance liabilities. We are self-insured for most employee healthcare, workers’ compensation and automobile liability costs; however, we maintain insurance for individual losses exceeding certain limits. Liabilities are estimated for healthcare costs using current and historical claims data. Liabilities for workers’ compensation and automobile liability claims are estimated using historical claims data and loss development factors. If the underlying facts and circumstances of existing claims change or historical trends are not indicative of future trends, then we may be required to record additional expense that could have a material effect on the results of operations. Self-insurance liabilities recorded in our consolidated balance sheet for employee healthcare, workers’ compensation and automobile liability costs totaled $13.9 million at December 31, 2013. Supplier incentives. We have contractual arrangements with certain suppliers that provide incentives, including operational efficiency and performance-based incentives, on a monthly, quarterly or annual basis. These incentives are recognized as a reduction in cost of goods sold as targets become probable of achievement. Supplier incentives receivable are recorded for interim and annual reporting purposes and are based on our estimate of the amounts which are expected to be realized. If we do not achieve required targets under certain programs as estimated, it could have a material adverse effect on our results of operations. Business Combinations. We allocate the fair value of purchase consideration to the tangible assets acquired, liabilities assumed and intangible assets acquired based on their estimated fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. When determining the fair values of assets acquired and liabilities assumed, management makes significant estimates and assumptions, especially with respect to intangible assets. Critical estimates in valuing certain intangible assets include but are not limited to future expected cash flows from customer relationships and discount rates. Our estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. Recent Accounting Pronouncements For a discussion of recent accounting pronouncements, see Note 1 of Notes to the Consolidated Financial Statements. Item 7A. Quantitative and Qualitative Disclosures About Market Risk We are exposed to market risk from changes in interest rates related to our revolving credit facility. We had no outstanding borrowings and $5.0 million in letters of credit under the facility at December 31, 2013. A hypothetical increase in interest rates of 100 basis points would result in a potential reduction in future pre-tax earnings of approximately $0.1 million per year for every $10 million of outstanding borrowings under the revolving credit facility. 23 Due to the nature and pricing of our Domestic segment distribution services, we are exposed to potential volatility in fuel prices. Our strategies for helping to mitigate our exposure to changing domestic fuel prices has included entering into leases for trucks with improved fuel efficiency and entering into fixed–price agreements for diesel fuel. We benchmark our domestic diesel fuel purchase prices against the U.S. Weekly Retail On-Highway Diesel Prices (benchmark) as quoted by the U.S. Energy Information Administration. The benchmark averaged $3.92 per gallon in 2013, decreased 1% from $3.97 per gallon in 2012. Based on our fuel consumption in 2013, we estimate that every 10 cents per gallon increase in the benchmark would reduce our Domestic segment operating earnings by approximately $0.4 million. In January 2013, we entered into a fixed-price purchase agreement with one of our diesel fuel suppliers for approximately one-third of our anticipated Domestic segment fuel usage for 2013 at an equivalent benchmark price of $3.91 per gallon. We have not entered into a similar agreement for 2014. In the normal course of business, we are exposed to foreign currency translation and transaction risks. Our business transactions outside of the United States are primarily denominated in the Euro and British Pound. We may use foreign currency forwards, swaps and options, where possible, to manage our risk related to certain foreign currency fluctuations. However, we believe that our foreign currency transaction risks are low since our revenues and expenses are typically denominated in the same currency. Item 8. Financial Statements and Supplementary Data See Item 15. Exhibits and Financial Statement Schedules. Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure None. Item 9A. Controls and Procedures We carried out an evaluation, with the participation of management, including our principal executive officer and principal financial officer, of the effectiveness of our disclosure controls and procedures (pursuant to Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended) as of the end of the period covered by this report. Based upon that evaluation, the principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective as of December 31, 2013. There has been no change in our internal control over financial reporting during our last fiscal quarter (our fourth quarter in the case of an annual report) ended December 31, 2013, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. Item 9B. Other Information Not applicable. 24 Management’s Report on Internal Control over Financial Reporting Management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f), for Owens & Minor, Inc. (the company). Under the supervision and with the participation of management, including the company’s principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting as of December 31, 2013, based on the framework in Internal Control—Integrated Framework (1992) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on our evaluation under the COSO framework, management concluded that the company’s internal control over financial reporting was effective as of December 31, 2013. The effectiveness of the company’s internal control over financial reporting as of December 31, 2013, has been audited by KPMG LLP, an independent registered public accounting firm, as stated in their report which is included in this annual report. /s/ Craig R. Smith Craig R. Smith Chairman & Chief Executive Officer /s/ Richard A. Meier Richard A. Meier Executive Vice President & Chief Financial Officer 25 Report of Independent Registered Public Accounting Firm The Board of Directors and Shareholders Owens & Minor, Inc.: We have audited Owens & Minor, Inc.’s internal control over financial reporting as of December 31, 2013, based on criteria established in Internal Control - Integrated Framework (1992) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Owens & Minor, Inc.’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion. A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. In our opinion, Owens & Minor, Inc. maintained, in all material respects, effective internal control over financial reporting as of December 31, 2013, based on criteria established in Internal Control - Integrated Framework (1992) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheets of Owens & Minor, Inc. and subsidiaries as of December 31, 2013 and 2012, and the related consolidated statements of income, comprehensive income, changes in shareholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2013 and our report dated February 24, 2014, expressed an unqualified opinion on those consolidated financial statements. Richmond, Virginia February 24, 2014 26 Items 10-14. Part III Information required by Items 10-14 can be found under Corporate Officers on page 8 of the Annual Report (or at the end of the electronic filing of this Form 10-K) and the registrant’s 2014 Proxy Statement pursuant to instructions (1) and G (3) of the General Instructions to Form 10-K. Because our common stock is listed on the New York Stock Exchange (NYSE), our Chief Executive Officer is required to make, and he has made, an annual certification to the NYSE stating that he was not aware of any violation by of the corporate governance listing standards of the NYSE. Our Chief Executive Officer made his annual certification to that effect to the NYSE as of May 14, 2013. In addition, we have filed, as exhibits to this Annual Report on Form 10-K, the certifications of our principal executive officer and principal financial officer required under Sections 906 and 302 of the Sarbanes-Oxley Act of 2002 to be filed with the Securities and Exchange Commission regarding the quality of our public disclosure. 27 Item 15. Exhibits and Financial Statement Schedules a) The following documents are filed as part of this report: Part IV Consolidated Statements of Income for the Years Ended December 31, 2013, 2012 and 2011 . . . . . . . . . . . . . . Consolidated Statements of Comprehensive Income for the Years Ended December 31, 2013, 2012, and 2011 . Consolidated Balance Sheets as of December 31, 2013 and 2012. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Consolidated Statements of Cash Flows for the Years Ended December 31, 2013, 2012 and 2011 . . . . . . . . . . . Consolidated Statements of Changes in Shareholders' Equity for the Years Ended December 31, 2013, 2012 and 2011 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Notes to Consolidated Financial Statements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Report of Independent Registered Public Accounting Firm . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Selected Quarterly Financial Information (unaudited). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Page 29 30 31 32 33 34 61 62 b) Exhibits: See Index to Exhibits on page 63. 28 OWENS & MINOR, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF INCOME (in thousands, except per share data) Year ended December 31, Net revenue Cost of goods sold Gross margin Selling, general, and administrative expenses Acquisition-related and exit and realignment charges Depreciation and amortization Other operating income, net Operating earnings Interest expense, net Income before income taxes Income tax provision Net income $ 2013 9,071,532 7,954,457 1,117,075 863,656 12,444 50,586 (7,694) 198,083 13,098 184,985 74,103 $ 2012 8,868,324 7,943,670 $ 2011 8,627,912 7,770,375 924,654 682,595 10,164 39,604 (4,462) 196,753 13,397 183,356 74,353 857,537 610,657 13,168 34,135 (3,938) 203,515 13,682 189,833 74,635 $ 110,882 $ 109,003 $ 115,198 Net income attributable to Owens & Minor, Inc. per common share: Basic Diluted Cash dividends per common share $ $ $ 1.76 1.76 0.96 $ $ $ 1.72 1.72 0.88 $ $ $ 1.82 1.81 0.80 See accompanying notes to consolidated financial statements. 29 OWENS & MINOR, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (in thousands) Year ended December 31, Net income Other comprehensive income, net of tax: Currency translation adjustments (net of income tax expense of $111 in 2013 and $210 in 2012) Change in unrecognized net periodic pension costs (net of income tax expense of $2,429 in 2013 and income tax benefit of $1,671 in 2012 and $1,488 in 2011) Other (net of income tax expense of $32 in 2013, 2012 and 2011) Other comprehensive income (loss) Comprehensive income 2013 2012 2011 $ 110,882 $ 109,003 $ 115,198 6,143 9,749 — 3,839 (8) 9,974 (2,611) (50) 7,088 $ 120,856 $ 116,091 $ (2,328) (50) (2,378) 112,820 See accompanying notes to consolidated financial statements. 30 OWENS & MINOR, INC. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS (in thousands, except per share data) December 31, Assets Current assets Cash and cash equivalents Accounts and notes receivable, net Merchandise inventories Other current assets Total current assets Property and equipment, net Goodwill, net Intangible assets, net Other assets, net Total assets Liabilities and equity Current liabilities Accounts payable Accrued payroll and related liabilities Deferred income taxes Other current liabilities Total current liabilities Long-term debt, excluding current portion Deferred income taxes Other liabilities Total liabilities Commitments and contingencies Equity Owens & Minor, Inc. shareholders’ equity Preferred stock, par value $100 per share, authorized—10,000 shares, Series A Participating Cumulative Preferred Stock; none issued Common stock, par value $2 per share; authorized—200,000 shares; issued and outstanding—63,096 shares and 63,271 shares Paid-in capital Retained earnings Accumulated other comprehensive loss Total Owens & Minor, Inc. shareholders’ equity Noncontrolling interest Total equity Total liabilities and equity See accompanying notes to consolidated financial statements. 31 2013 2012 $ 101,905 $ 572,854 771,663 279,510 97,888 537,335 763,756 231,264 1,725,932 1,630,243 191,961 275,439 40,406 90,304 191,841 274,884 42,313 75,117 $ 2,324,042 $ 2,214,398 $ 643,872 $ 603,137 23,296 41,613 280,398 989,179 213,815 43,727 52,278 25,468 42,107 254,924 925,636 215,383 36,269 63,454 1,298,999 1,240,742 — — 126,193 196,605 691,547 9,568 1,023,913 1,130 1,025,043 126,544 187,394 658,994 (406) 972,526 1,130 973,656 $ 2,324,042 $ 2,214,398 OWENS & MINOR, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS (in thousands) Year ended December 31, Operating activities: Net income Adjustments to reconcile net income to cash provided by operating activities of continuing operations: Depreciation and amortization Share-based compensation expense Deferred income tax expense Provision for losses on accounts and notes receivable Pension contributions Changes in operating assets and liabilities: Accounts and notes receivable Merchandise inventories Accounts payable Net change in other assets and liabilities Other, net Cash provided by operating activities of continuing operations Investing activities: Acquisition, net of cash acquired Additions to computer software and intangible assets Additions to property and equipment Proceeds from sale of property and equipment Cash used for investing activities of continuing operations Financing activities: Cash dividends paid Repurchases of common stock Financing costs paid Proceeds from exercise of stock options Excess tax benefits related to share-based compensation Proceeds from termination of interest rate swaps Other, net Cash used for financing activities of continuing operations Discontinued operations: Operating cash flows Net cash used for discontinued operations Effect of exchange rate changes on cash and cash equivalents Net increase (decrease) in cash and cash equivalents Cash and cash equivalents at beginning of year Cash and cash equivalents at end of year 2013 2012 2011 $ 110,882 $ 109,003 $ 115,198 50,586 6,381 3,713 787 — (38,645) (7,064) 47,374 (32,337) (1,123) 140,554 — (32,010) (28,119) 3,051 (57,078) (60,731) (18,876) — 5,352 898 — (8,623) (81,980) — — 2,521 4,017 97,888 39,604 5,697 1,060 1,004 — 27,161 58,734 (18,694) (4,490) (573) 218,506 (155,210) (29,131) (9,832) 3,298 (190,875) (55,681) (15,000) (1,303) 4,986 1,293 — (2,710) (68,415) — — 2,734 (38,050) 135,938 34,135 5,674 14,520 2,176 (409) (37,273) (86,250) 44,058 (24,654) 1,244 68,419 — (11,334) (24,981) 2,430 (33,885) (50,909) (16,124) — 9,179 2,154 4,005 (5,836) (57,531) (278) (278) — (23,275) 159,213 $ 101,905 $ 97,888 $ 135,938 See accompanying notes to consolidated financial statements. 32 OWENS & MINOR, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY (in thousands, except per share data) Owens & Minor, Inc. Shareholders’ Equity Common Shares Outstanding Common Stock ($2 par value) Paid-In Capital Retained Earnings Accumulated Other Comprehensive Income (Loss) Noncontrolling Interest Total Equity Balance, December 31, 2010 63,433 $ 126,867 $ 165,447 $ 570,320 $ (5,116) $ — $ 857,518 Net income Other comprehensive loss Non-cash contribution from noncontrolling interest Dividends declared ($0.80 per share) Shares repurchased and retired (524) (1,048) Share-based compensation expense, exercises and other 540 1,081 Balance, December 31, 2011 63,449 126,900 13,605 179,052 Net income Other comprehensive income Dividends declared ($0.88 per share) Shares repurchased and retired Share-based compensation expense, exercises and other Balance, December 31, 2012 Net income Other comprehensive income Dividends declared ($0.96 per share) (522) (1,043) 344 687 8,342 63,271 126,544 187,394 Shares repurchased and retired (560) (1,120) Share-based compensation expense, exercises and other Balance, December 31, 2013 385 63,096 769 $ 126,193 9,211 $ 196,605 115,198 (2,378) 115,198 (2,378) 1,130 1,130 (50,813) (15,076) 619,629 109,003 (55,681) (13,957) 658,994 110,882 (60,573) (17,756) (7,494) 1,130 7,088 (406) 1,130 9,974 (50,813) (16,124) 14,686 919,217 109,003 7,088 (55,681) (15,000) 9,029 973,656 110,882 9,974 (60,573) (18,876) $ 691,547 $ 9,568 $ 1,130 9,980 $1,025,043 See accompanying notes to consolidated financial statements. 33 OWENS & MINOR, INC. AND SUBSIDIARIES Notes to Consolidated Financial Statements (in thousands, unless otherwise indicated) Note 1—Summary of Significant Accounting Policies Owens & Minor, Inc. and subsidiaries (we, us or our), a Fortune 500 company headquartered in Richmond, Virginia. We are a leading healthcare services company that connects the world of medical products to the point of care by providing vital supply chain assistance to the providers of healthcare services and the manufacturers of healthcare products, supplies, and devices in the United States and Europe. We serve our customers with a service portfolio that covers procurement, inventory management, delivery and sourcing for the healthcare market. With fully developed networks in the United States and Europe, we are equipped to serve a customer base ranging from hospitals, integrated healthcare systems, group purchasing organizations, and the U.S. federal government, to manufacturers of life-science and medical devices and supplies, including pharmaceuticals in Europe. Our Domestic segment includes all functions in the United States relating to our role as a healthcare services company providing distribution and logistics services to healthcare providers and manufacturers. The International segment consists of Movianto, our European third-party logistics service. Basis of Presentation. The consolidated financial statements include the accounts of Owens & Minor, Inc. and the subsidiaries it controls, in conformity with U.S generally accepted accounting principles (GAAP). For the consolidated subsidiary in which our ownership is less than 100%, the outside stockholder’s interest is presented as a noncontrolling interest. All significant intercompany accounts and transactions have been eliminated. Reclassifications and Correction. Certain prior year amounts have been reclassified to conform to current year presentation. In addition, after completing a review of customer contracts in the International segment, we have determined a net presentation of revenues for certain contracts is more representative of the customer arrangement. Certain 2012 amounts have been revised to reflect this net presentation of revenues. Net revenue and cost of goods sold each decreased by $39.8 million, accounts and notes receivable, net decreased by $16.2 million and other current assets increased by $16.2 million. The change did not affect cash flows, gross margin, operating earnings or net income in 2012. Use of Estimates. The preparation of the consolidated financial statements in conformity with GAAP requires us to make assumptions and estimates that affect reported amounts and related disclosures. Estimates are used for, but are not limited to, the allowances for losses on accounts and notes receivable, inventory valuation allowances, supplier incentives, depreciation and amortization, goodwill valuation, valuation of intangible assets and other long-lived assets, valuation of property held for sale, self-insurance liabilities, tax liabilities, defined benefit obligations, share-based compensation and other contingencies. Actual results may differ from these estimates. Cash and Cash Equivalents. Cash and cash equivalents includes cash and marketable securities with an original maturity or maturity at acquisition of three months or less. Cash and cash equivalents are stated at cost. Nearly all of our cash and cash equivalents are held in cash depository accounts in major banks in the United States and Europe. Book overdrafts represent the amount of outstanding checks issued in excess of related bank balances and are included in accounts payable in our consolidated balance sheets, as they are similar to trade payables and are not subject to finance charges or interest. Changes in book overdrafts are classified as operating activities in our consolidated statements of cash flows. Accounts and Notes Receivable, Net. Accounts receivable from customers are recorded at the invoiced amount. We assess finance charges on overdue accounts receivable that are recognized as other operating income based on their estimated ultimate collectability. We have arrangements with certain customers under which they make deposits on account. Customer deposits in excess of outstanding receivable balances are classified as other current liabilities. We maintain valuation allowances based upon the expected collectability of accounts and notes receivable. Our allowances include specific amounts for accounts that are likely to be uncollectible, such as customer bankruptcies and disputed amounts and general allowances for accounts that may become uncollectible. Allowances are estimated based on a number of factors, including industry trends, current economic conditions, creditworthiness of customers, age of the receivables, changes in customer payment patterns, and historical experience. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. 34 Financing Receivables and Payables. We have an order-to-cash program in our International segment under which we invoice manufacturers’ customers and remit collected amounts to the manufacturers. We retain credit risk for uncollected receivables under this program. We continually monitor the expected collectability in this program and maintain valuation allowances when it is likely that an amount may be or may become uncollectible. Allowances are estimated based on a number of factors including creditworthiness of customers, age of the receivables and historical experience. We write off uncollected receivables under this program when collection is no longer being pursued. At December 31, 2013 the allowance for uncollectible accounts as part of this program was $0.1 million and there was no allowance for uncollectible accounts as part of this program in 2012. Fees charged for this program are included in net revenue. Product pricing and related product risks are retained by the manufacturer. Balances receivable and related amounts payable under this program are classified in other current assets and other current liabilities in the consolidated balance sheet. Merchandise Inventories. Merchandise inventories are valued at the lower of cost or market, with cost determined by the last-in, first-out (LIFO) method for Domestic segment inventories. Cost of International segment inventories is determined using the first-in, first out (FIFO) method. Property and Equipment. Property and equipment are stated at cost less accumulated depreciation or, if acquired under capital leases, at the lower of the present value of minimum lease payments or fair market value at the inception of the lease less accumulated amortization. Depreciation and amortization expense for financial reporting purposes is computed on a straight-line method over the estimated useful lives of the assets or, for capital leases and leasehold improvements, over the term of the lease, if shorter. In general, the estimated useful lives for computing depreciation and amortization are four to 15 years for warehouse equipment, five to 40 years for buildings and building improvements, and three to eight years for computers, furniture and fixtures, and office and other equipment. Straight-line and accelerated methods of depreciation are used for income tax purposes. Normal maintenance and repairs are expensed as incurred, and renovations and betterments are capitalized. Leases. We have entered into non-cancelable agreements to lease most of our office and warehouse facilities with remaining terms generally ranging from one to ten years. We also lease most of our transportation and material handling equipment for terms generally ranging from three to ten years. Certain information technology assets embedded in an outsourcing agreement are accounted for as capital leases. Leases are classified as operating leases or capital leases at their inception. Rent expense for leases with rent holidays or pre-determined rent increases are recognized on a straight-line basis over the lease term. Incentives and allowances for leasehold improvements are deferred and recognized as a reduction of rent expense over the lease term. Goodwill. We evaluate goodwill for impairment annually, as of April 30, and whenever events occur or changes in circumstance indicate that the carrying amount of goodwill may not be recoverable. We review goodwill first by performing a qualitative assessment to determine if it is more likely than not that the fair value of a reporting unit exceeds its carrying value. If not, we then perform a quantitative assessment by first comparing the carrying amount to the fair value of the reporting unit. If the fair value of the reporting unit is determined to be less than its carrying value, a second step is performed to measure the goodwill impairment loss as the excess of the carrying value of the reporting unit’s goodwill over the estimated fair value of its goodwill. We estimate the fair value of the reporting unit using valuation techniques which can include comparable multiples of the unit’s earnings before interest, taxes, depreciation and amortization (EBITDA) and present value of expected cash flows. The EBITDA multiples are based on an analysis of current enterprise values and recent acquisition prices of similar companies, if available. Intangible Assets. Intangible assets acquired through purchases or business combinations are stated at fair value at the acquisition date and net of accumulated amortization in the consolidated balance sheets. Intangible assets, consisting primarily of customer relationships, customer contracts, non-competition agreements, trademarks, and tradenames are amortized over their estimated useful lives. In determining the useful life of an intangible asset, we consider our historical experience in renewing or extending similar arrangements. Customer relationships are generally amortized over 10 to 15 years and other intangible assets are amortized generally for periods between one and 15 years, based on their pattern of economic benefit or on a straight-line basis. Computer Software. We develop and purchase software for internal use. Software development costs incurred during the application development stage are capitalized. Once the software has been installed and tested, and is ready for use, additional costs incurred in connection with the software are expensed as incurred. Capitalized computer software costs are amortized over the estimated useful life of the software, usually between three and ten years. Computer software costs are included in other assets, net, in the consolidated balance sheets. Unamortized software at December 31, 2013 and 2012 was $74.4 million and $59.7 million. Depreciation and amortization expense includes $14.2 million, $11.0 million and $9.9 million of software amortization for the years ended December 31, 2013, 2012 and 2011. 35 Long-Lived Assets. Long-lived assets, which include property and equipment, finite-lived intangible assets, and unamortized software costs, are evaluated for impairment whenever events or changes in circumstances indicate that the carrying amount of long-lived assets may not be recoverable. We assess long-lived assets for potential impairment by comparing the carrying value of an asset, or group of related assets, to their estimated undiscounted future cash flows. Self-Insurance Liabilities. We are self-insured for most employee healthcare, workers’ compensation and automobile liability costs; however, we maintain insurance for individual losses exceeding certain limits. Liabilities are estimated for healthcare costs using current and historical claims data. Liabilities for workers’ compensation and automobile liability claims are estimated using historical claims data and loss development factors. If the underlying facts and circumstances of existing claims change or historical trends are not indicative of future trends, then we may be required to record additional expense or reductions to expense. Self-insurance liabilities are included in other accrued liabilities on the consolidated balance sheets. Revenue Recognition. Revenue is recognized when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the price or fee is fixed or determinable, and collectability is reasonably assured. Under most of our distribution contracts, title passes to the customer when the product is received by the customer. We record product revenue at the time that shipment is completed. Distribution fee revenue, when calculated as a mark-up of the product cost, is also recognized at the time that shipment is completed. Revenue for activity-based fees and other services is recognized as work is performed and as amounts are earned. Depending on the specific contractual provisions and nature of the deliverable, revenue from services may be recognized on a straight-line basis over the term of the service, on a proportional performance model, based on level of effort, or when final deliverables have been provided. Additionally, we generate fees from arrangements that include performance targets related to cost-saving initiatives for customers that result from our supply-chain management services. Achievement against performance targets, measured in accordance with contractual terms, may result in additional fees paid to us or, if performance targets are not achieved, we may be obligated to refund or reduce a portion of our fees to provide credits toward future purchases by the customer. For these arrangements, all contingent revenue is deferred and recognized as the performance target is achieved and the applicable contingency is released. When we determine that a loss is probable under a contract, the estimated loss is accrued. We allocate revenue for arrangements with multiple deliverables meeting the criteria for a separate unit of accounting using the relative selling price method and recognize revenue for each deliverable in accordance with applicable revenue recognition criteria. In most cases, we record revenue gross, as we are the primary obligor in our sales arrangements, bear the risk of general and physical inventory loss and carry all credit risk associated with sales. When we act as an agent in a sales arrangement and do not bear a significant portion of these risks, primarily for our third-party logistics business, we record revenue net of product cost. Sales taxes collected from customers and remitted to governmental authorities are excluded from revenues. Selling, General and Administrative (SG&A) Expenses. SG&A expenses include labor and warehousing costs associated with our distribution and third-party logistics services, as well as labor costs for our supply-chain consulting services. Shipping and handling costs are included in SG&A expenses on the consolidated statements of income and include costs to store, move and prepare products for shipment, as well as costs to deliver products to customers. Shipping and handling costs billed to customers are included in net revenues. Freight costs incurred for shipments of products from manufacturers to our distribution centers are included in cost of goods sold. Supplier Incentives. We have contractual arrangements with certain suppliers that provide incentives, including cash discounts for prompt payment, operational efficiency and performance-based incentives. These incentives are recognized as a reduction in cost of goods sold as targets become probable of achievement. Share-Based Compensation. We account for share-based payments to employees at fair value and recognize the related expense in selling, general and administrative expenses over the service period for awards expected to vest. 36 Derivative Financial Instruments. We periodically enter into interest rate swaps as part of our interest rate risk management strategy. The purpose of these swaps is to maintain a mix of fixed to floating rate financing in order to manage interest rate risk. Generally, the interest rate swaps are designated as fair value hedges of specified portions of long-term debt using the shortcut method, when both the swaps and the long-term debt meet all of the conditions for the use of this method. Accordingly, no net gains or losses are typically recorded in the consolidated statements of income related to changes in the fair value of the underlying debt and interest rate swaps. These swaps are recognized on the balance sheet at their fair value, which is determined by using observable market inputs (Level 2). There were no outstanding derivative instruments at December 31, 2013 or 2012. Income Taxes. We account for income taxes under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income from continuing operations in the period that includes the enactment date. Valuation allowances are provided if it is more likely than not that a deferred tax asset will not be realized. When we have claimed tax benefits that may be challenged by a tax authority, an estimate of the effect of these uncertain tax positions is recorded. It is our policy to provide for uncertain tax positions and the related interest and penalties based upon an assessment of whether a tax benefit is more likely than not to be sustained upon examination by tax authorities. To the extent that the tax outcome of these uncertain tax positions changes, based on our assessment, such changes in estimate may impact the income tax provision in the period in which such determination is made. We earn a portion of our operating earnings in foreign jurisdictions outside the United States, which we consider to be indefinitely reinvested. Accordingly, no United States federal and state income taxes and withholding taxes have been provided on these earnings. Our cash, cash-equivalents, short-term investments, and marketable securities held by our foreign subsidiaries totaled $22.2 million and $24.9 million as of December 31, 2013 and 2012. We do not intend, nor do we foresee a need, to repatriate these funds or other assets held outside the U.S. In the future, should we require more capital to fund discretionary activities in the U.S. than is generated by our domestic operations and is available through our borrowings, we could elect to repatriate cash or other assets from foreign jurisdictions that have previously been considered to be indefinitely reinvested. Upon distribution of these assets, we could be subject to additional U.S. federal and state income taxes and withholding taxes payable to foreign jurisdictions, where applicable. Fair Value Measurements. Fair value is determined based on assumptions that a market participant would use in pricing an asset or liability. The assumptions used are in accordance with a three-tier hierarchy, defined by GAAP, that draws a distinction between market participant assumptions based on (i) observable inputs such as quoted prices in active markets (Level 1), (ii) inputs other than quoted prices in active markets that are observable either directly or indirectly (Level 2) and (iii) unobservable inputs that require the use of present value and other valuation techniques in the determination of fair value (Level 3). The carrying amounts of cash and cash equivalents, accounts receivable and accounts payable reported in the consolidated balance sheets approximate fair value due to the short-term nature of these instruments. Property held for sale is reported at estimated fair value less selling costs with fair value determined based on recent sales prices for comparable properties in similar locations (Level 2). The fair value of long-term debt is estimated based on quoted market prices or dealer quotes for the identical liability when traded as an asset in an active market (Level 1) or, if quoted market prices or dealer quotes are not available, on the borrowing rates currently available for loans with similar terms, credit ratings, and average remaining maturities (Level 2). See Notes 7, 10 and 11 for the fair value of property held for sale, debt instruments and interest rate swaps. Acquisition-Related and Exit and Realignment Costs. We present costs incurred in connection with acquisitions in acquisition-related and exit and realignment charges in our consolidated statements of income. Acquisition-related charges consist primarily of transaction costs incurred to perform due diligence and to analyze, negotiate and consummate an acquisition, costs to perform post-closing activities to establish a tax-efficient organizational structure, and costs to transition the acquired company’s information technology and other operations and administrative functions from the former owner. Costs associated with exit and realignment activities are recorded at their fair value when incurred. Liabilities are established at the cease-use date for remaining operating lease and other contractual obligations, net of estimated sub-lease income. The net lease termination cost is discounted using a credit-adjusted risk-free rate of interest. We evaluate these assumptions quarterly and adjust the liability accordingly. The current portion of accrued lease and other contractual termination costs is included in other accrued liabilities on the consolidated balance sheets, and the non-current portion is included in other liabilities. Severance benefits are recorded when payment is considered probable and reasonably estimable. 37 Income Per Share. Basic and diluted income per share are calculated pursuant to the two-class method, under which unvested share-based payment awards containing nonforfeitable rights to dividends are participating securities. Foreign Currency Translation. Our foreign subsidiaries generally consider their local currency to be their functional currency. Assets and liabilities of these foreign subsidiaries are translated into U.S. dollars at period-end exchange rates and revenues and expenses are translated at average exchange rates during the period. Cumulative currency translation adjustments are included in accumulated other comprehensive income (loss) in shareholders’ equity. Gains and losses on intercompany foreign currency transactions that are long-term in nature and which we do not intend to settle in the foreseeable future are also recognized in other comprehensive income (loss) in shareholders’ equity. Realized gains and losses from foreign currency transactions are recorded in other operating income, net in the consolidated statements of income and were not material to our consolidated results of operations in 2013, 2012, and 2011. Business Combinations. We account for acquired businesses using the acquisition method of accounting, which requires that the assets acquired and liabilities assumed be recorded at the date of acquisition at their respective fair values. Any excess of the purchase price over the estimated fair values of the net assets acquired is recorded as goodwill. Recent Accounting Pronouncements. During 2013, we adopted Accounting Standard Updates (ASU’s) issued by the Financial Accounting Standards Board (FASB). We adopted an ASU issued by the Financial Accounting Standards Board (FASB) for clarifying disclosures of offsetting assets and liabilities. This clarifies the scope and treatment of derivatives that are offset or subject to an enforceable master netting arrangement. The adoption of this guidance did not have an impact on our financial position or results of operations. We adopted an ASU for reporting amounts reclassified out of accumulated other comprehensive income. This update requires entities to disclose the amounts reclassified out of accumulated other comprehensive income by component. The adoption of this guidance did not have an impact on our financial position or results of operations. We have adopted an ASU for reporting cumulative translation adjustment upon derecognition of foreign subsidiaries, assets or investments. This update requires the release of related cumulative translation adjustment when the parent ceases to have a controlling financial interest. The adoption of this guidance did not have an impact on our financial position or results of operations. Note 2—Significant Risks and Uncertainties Many of our hospital customers in the U.S. are represented by group purchasing organizations (GPOs) that contract with us for services on behalf of the GPO members. GPOs representing a significant portion of our business are Novation, LLC (Novation), MedAssets Inc. (MedAssets) and Premier, Inc. (Premier). Members of these GPOs have incentives to purchase from their primary selected distributor; however, they operate independently and are free to negotiate directly with distributors and manufacturers. For 2013, 2012 and 2011, net revenue from hospitals under contract with these GPOs represented the following percentages of our net revenue annually: Novation—32% to 35%; MedAssets (including Broadlane in 2012 and 2011)—24%; and Premier—20% to 22%. Net revenue from sales of product supplied by subsidiaries of Covidien Ltd. and Johnson & Johnson Healthcare Systems, Inc. represented approximately 13% and 10% of our net revenue annually for 2013, 2012 and 2011, respectively. Note 3—Acquisition On August 31, 2012, we acquired from Celesio AG (Celesio) all of the voting interests of certain subsidiaries comprising the majority of Celesio’s healthcare third-party logistics business known as the Movianto Group (the acquired portion is referred to herein as Movianto) for consideration of approximately $157.3 million (€125 million ), net of cash acquired and including debt assumed of $2.1 million (primarily capitalized lease obligations). As a result of the acquisition of Movianto, we have entered into third-party logistics for the pharmaceutical and medical device industries in the European market with an existing platform that also expands our ability to serve our U.S.-based manufacturer customers globally. 38 The purchase price was allocated to the underlying assets acquired and liabilities assumed based upon our estimate of their fair values at the date of acquisition, with certain exceptions permitted under GAAP. The purchase price exceeded the estimated fair value of the net tangible and identifiable intangible assets by $25.4 million, which was allocated to goodwill. The following table presents the estimated fair value of the assets acquired and liabilities assumed recognized as of the acquisition date. Assets acquired: Current assets Property and equipment Goodwill Intangible assets Other noncurrent assets Total assets Liabilities assumed: Current liabilities Noncurrent liabilities Total liabilities Preliminary Fair Value Estimated as of Acquisition Date(1) Measurement Period Adjustments Recorded in 2013 $ 211,052 $ 90,729 25,042 21,543 11,664 360,030 190,485 12,237 202,722 295 (2,385) 387 1,335 512 144 414 (270) 144 Fair value of net assets acquired, net of cash $ 157,308 $ — $ Fair Value as of Acquisition Date $ 211,347 88,344 25,429 22,878 12,176 360,174 190,899 11,967 202,866 157,308 (1) As previously reported in our 2012 Form 10-K. We are amortizing the fair value of acquired intangible assets, primarily customer relationships, over their remaining weighted average useful lives of 9 years. Goodwill of $25.4 million consists largely of expected opportunities to provide additional services to existing manufacturer customers and to expand our third-party logistics services globally. All of the goodwill was assigned to our International segment. None of the goodwill recognized is expected to be deductible for income tax purposes. The fair value of financial assets and financial liabilities acquired included financing receivables with a fair value of $106.8 million and financing payables with a fair value of $130.4 million. Acquisition-related costs consist primarily of transaction costs incurred to perform due diligence and to analyze, negotiate and consummate the acquisition, costs to perform post-closing activities to establish a tax-efficient organizational structure, and costs to transition the acquired company's information technology and other operating and administrative functions from the former owner. We recognized pre-tax acquisition-related expenses of $3.5 million and $10.5 million for the years ended December 31, 2013 and 2012. Note 4—Accounts and Notes Receivable, Net Allowances for losses on accounts and notes receivable of $15.0 million, $14.7 million and $15.6 million have been applied as reductions of accounts receivable at December 31, 2013, 2012, and 2011. Write-offs of accounts and notes receivable were $1.1 million, $1.9 million and $2.0 million for 2013, 2012 and 2011. Note 5—Merchandise Inventories At December 31, 2013 and 2012, we had inventory of $771.7 million and $763.8 million, of which $749.5 million and $749.4 million were valued under LIFO. If LIFO inventories had been valued on a current cost or first-in, first-out (FIFO) basis, they would have been greater by $108.6 million and $110.9 million as of December 31, 2013 and 2012. 39 Note 6—Financing Receivables and Payables At December 31, 2013 and 2012, we had financing receivables of $198.5 million and $140.7 million and related payables of $165.3 million and $130.1 million outstanding under our order-to-cash program, which were included in other current assets and other current liabilities, respectively, in the consolidated balance sheet. Note 7—Property and Equipment Property and equipment consists of the following: December 31, Warehouse equipment Computer equipment Building and improvements Leasehold improvements Land and improvements Furniture and fixtures Office equipment and other Accumulated depreciation and amortization Property and equipment, net 2013 160,379 $ 2012 $ 148,037 31,784 50,225 49,879 17,489 11,491 36,007 52,881 43,378 16,269 11,132 8,240 329,487 (137,526) 191,961 $ 6,010 313,714 (121,873) 191,841 $ Depreciation and amortization expense for property and equipment was $33.1 million, $26.1 million, and $21.2 million for the years ended December 31, 2013, 2012, and 2011. Property held for sale of $1.1 million at December 31, 2012 is included in other assets, net, in the consolidated balance sheets. We have no property classified as held for sale at December 31, 2013. Note 8—Goodwill and Intangible Assets The following table summarizes the changes in the carrying amount of goodwill through December 31, 2013: Carrying amount of goodwill, December 31, 2012 Currency translation adjustments Fair value adjustments (See Note 3) Carrying amount of goodwill, December 31, 2013 Domestic Segment International Segment Consolidated Total 248,498 $ 26,386 $ 274,884 — — 248,498 $ 168 387 26,941 $ 168 387 275,439 $ $ Intangible assets at December 31, 2013 and 2012 were as follows: Gross intangible assets Accumulated amortization Net intangible assets Weighted average useful life 2013 2012 Customer Relationships Other Intangibles Customer Relationships Other Intangibles $ $ 51,544 (14,281) 37,263 $ $ 3,933 (790) 3,143 $ $ 51,603 (11,717) 39,886 $ $ 2,848 (421) 2,427 13 years 6 years 13 years 6 years Gross intangible assets increased $1.3 million in 2013 as a result of finalizing the Movianto purchase price allocation (see Note 3), partially offset by the write-off of a fully amortized intangible for $0.3 million. Amortization expense for intangible assets was $3.3 million for 2013, $2.5 million for 2012, and $3.1 million for 2011. Based on the current carrying value of intangible assets subject to amortization, estimated amortization expense is $4.5 million for 2014, $5.0 million for 2015, $5.1 million for 2016, $5.0 million for 2017 and $4.2 million for 2018. 40 Note 9—Exit and Realignment Costs We periodically incur exit and realignment and other charges associated with optimizing our operations, which include the consolidation of distribution centers, the realignment of our distribution network, and the closure of offsite warehouses. In 2013, we expensed $8.9 million associated with these activities, of which $8.2 million was in the Domestic segment and $0.7 million was in the International segment. The charges include $3.1 million in loss accruals associated with our operating leases and estimated severance. The remaining charges of $5.8 million were comprised of costs that are expensed as incurred and not reflected in the table below, including $3.7 million in product move costs and the remainder in losses on property and equipment and other expenses. We expect additional exit and realignment charges of approximately $2.5 million over 2014 for activities initiated in the Domestic segment through December 31, 2013. During the fourth quarter of 2012, we expensed total charges in our Domestic segment of $2.2 million associated with exit and realignment activities. These charges include $1.1 million in employee severance. The remaining charges of $1.1 million are comprised of costs that were expensed as incurred and not reflected in the table below, including $0.8 million related to impairment losses associated with property and equipment and $0.3 million in other expenses. During 2011, we expensed total charges of $12.7 million associated with exit activities and our organizational realignment. These charges included loss accruals for operating leases of $8.4 million and employee severance costs of $3.0 million. The remaining charges of $1.3 million are comprised of costs that were expensed as incurred and not reflected in the table below, including losses associated with property and equipment and other expenses. In the fourth quarter of 2012, we recorded income of $2.6 million related to a favorable lease settlement associated with the 2011 activities. The following table summarizes the activity related to exit and realignment cost accruals through December 31, 2013: Lease obligations Severance and Other Total Accrued exit and realignment charges, January 1, 2011 $ — $ — $ Provision for exit and realignment activities Cash payments, net of sublease income Accrued exit and realignment charges, December 31, 2011 Provision for exit and realignment activities Change in estimate Interest accretion Cash payments, net of sublease income Accrued exit and realignment charges, December 31, 2012 Provision for exit and realignment activities Cash payments, net of sublease income Accrued exit and realignment charges, December 31, 2013 $ 8,362 (98) 8,264 95 (2,183) 267 (1,345) 5,098 2,932 (5,596) 2,434 3,002 (1,171) 1,831 1,088 — — (1,803) 1,116 128 (769) 475 $ $ — 11,364 (1,269) 10,095 1,183 (2,183) 267 (3,148) 6,214 3,060 (6,365) 2,909 Note 10—Debt Debt consists of the following: December 31, 6.35% Senior Notes, $ 200 million par value, maturing April 2016 Capital leases Total debt Less current maturities Long-term debt 2013 2012 Carrying Amount Estimated Fair Value Carrying Amount Estimated Fair Value $ 204,028 $ 218,750 $ 12,215 216,243 (2,428) 213,815 $ 12,215 230,965 (2,428) 228,537 $ $ 205,754 11,837 217,591 (2,208) 215,383 $ $ 219,500 11,837 231,337 (2,208) 229,129 41 At December 31, 2013 and 2012, we had $200 million of 6.35% Senior Notes outstanding, which mature on April 15, 2016 (Senior Notes). Interest on the Senior Notes is payable semi-annually on April 15 and October 15. We may redeem the Senior Notes, in whole or in part, at a redemption price of the greater of 100% of the principal amount of the Senior Notes or the present value of remaining scheduled payments of principal and interest discounted at the applicable Treasury Rate plus 0.25%. The observed yield of the senior notes at December 31, 2013 was 2.12%. On June 5, 2012, we entered into a five-year $350 million Credit Agreement with Wells Fargo Bank, N.A., JPMorgan Chase Bank, N.A. and a syndicate of financial institutions (the Credit Agreement) expiring June 5, 2017. This agreement replaced an existing $350 million credit agreement that expired June 7, 2013. Under the new credit facility, we have the ability to request two one-year extensions and to request an increase in aggregate commitments by up to $150 million. The interest rate on the new credit facility, which is subject to adjustment quarterly, is based on the London Interbank Offered Rate (LIBOR), the Federal Funds Rate or the Prime Rate, plus an adjustment based on the better of our debt ratings or leverage ratio (Credit Spread) as defined by the Credit Agreement. We are charged a commitment fee of between 17.5 and 42.5 basis points on the unused portion of the facility. The terms of the Credit Agreement limit the amount of indebtedness that we may incur and require us to maintain ratios for leverage and interest coverage, including on a pro forma basis in the event of an acquisition. At December 31, 2013 and 2012, we had no borrowings and letters of credit of $5.0 million outstanding on the revolving credit facility, leaving $345.0 million available for borrowing. We also had a $1.5 million and $1.4 million letter of credit supporting our European leased facilities outstanding as of December 31, 2013 and 2012 not issued under our Credit Agreement. The Revolving Credit Facility and Senior Notes contain cross-default provisions which could result in the acceleration of payments due in the event of default of either agreement. We believe we were in compliance with our debt covenants at December 31, 2013. We assumed debt (primarily capitalized lease obligations) of approximately $2.1 million with the acquisition of Movianto. Cash payments for interest during 2013, 2012 and 2011 were $14.7 million, $14.7 million and $14.1 million. Based on lease commitments outstanding at December 31, 2013, minimum capital lease payments, excluding interest, are $3.5 million in 2014, $2.9 million in 2015, $2.4 million in 2016, $1.6 million in 2017 and $1.0 million in 2018. Note 11—Derivative Financial Instruments In April 2011, we entered into interest rate swap agreements for an aggregate $175 million in notional amounts, under which we paid counterparties a variable rate based on the six-month LIBOR plus a spread of approximately 393 basis points, and the counterparties paid us a fixed rate of 6.35%. These agreements effectively converted 87.5% of our Senior Notes to variable-rate debt. The swaps were designated as fair value hedges of specified portions of the Senior Notes using the shortcut method, as both the swaps and the Senior Notes met all of the conditions for the use of this method. Accordingly, no net gains or losses were recorded in the consolidated statements of income related to changes in the fair value of the underlying debt and interest rate swap agreements. We terminated these swaps in July 2011 and received proceeds of $4.0 million, plus accrued interest of $0.8 million. The fair value adjustment of $4.0 million to the carrying value of the related debt, plus the remaining balance of a fair value adjustment related to interest rate swaps terminated in 2008, are being recognized as an offset to interest expense using the interest method over the remaining life of the debt. We did not hold any derivative financial instruments during 2012 or 2013. Note 12—Share-Based Compensation We maintain a share-based compensation plan (the Plan) that is administered by the Compensation and Benefits Committee of the Board of Directors. The Plan allows us to award or grant to officers, directors and employees incentive, non- qualified and deferred compensation stock options, stock appreciation rights (SARs), performance shares, and restricted and unrestricted stock. We use authorized and unissued common shares for grants of restricted stock or for stock option exercises. At December 31, 2013, approximately 2.0 million common shares were available for issuance under the Plan. Restricted stock awarded under the Plan generally vests over one, three or five years. Certain restricted stock grants contain accelerated vesting provisions, based on the satisfaction of certain performance criteria related to the achievement of certain financial and operational results. Performance shares awarded under the Plan are issuable as restricted stock upon meeting performance goals and vest over three years. Stock options awarded under the Plan are generally subject to graded vesting over three years and expire seven to ten years from the date of grant. The options are granted at a price equal to fair market value at the date of grant. We did not grant any stock options in 2013, 2012, or 2011. 42 We have a Management Equity Ownership Program that requires each of our officers to own common stock at specified levels, which gradually increase over five years. Officers and certain other employees who meet specified ownership goals in a given year are awarded restricted stock or performance shares under the provisions of the program. We recognize the fair value of stock-based compensation awards, which is based upon the market price of the underlying common stock at the grant date, on a straight-line basis over the estimated requisite service period, which may be based on a service condition, a performance condition, or a combination of both. The fair value of performance shares as of the date of grant is estimated assuming that performance goals will be achieved at target levels. If such goals are not probable of being met, or are probable of being met at different levels, recognized compensation cost is adjusted to reflect the change in estimated fair value of restricted stock to be issued at the end of the performance period. Total share-based compensation expense for December 31, 2013, 2012 and 2011, was $6.4 million, $5.7 million and $5.7 million, with recognized tax benefits of $2.5 million, $2.2 million and $2.2 million. Unrecognized compensation cost related to nonvested restricted stock awards, net of estimated forfeitures, was $10.2 million at December 31, 2013. This amount is expected to be recognized over a weighted-average period of 2.3 years, based on the maximum remaining vesting period required under the awards, and the amount that would be recognized over a shorter period based on accelerated vesting provisions, is approximately $0.5 million. Unrecognized compensation cost related to nonvested performance share awards as of December 31, 2013 was $1.7 million and will be recognized primarily in 2014 if the related performance targets are met. The following table summarizes the activity and value of nonvested restricted stock and performance share awards for the years ended December 31, 2013, 2012 and 2011: 2013 2012 2011 Number of Shares (000’s) Weighted Average Grant-date Value (per share) Number of Shares (000’s) Weighted Average Grant-date Value (per share) Number of Shares (000’s) Weighted Average Grant-date Value (per share) Nonvested awards at beginning of year Granted Vested Forfeited Nonvested awards at end of year $ 720 339 (206) (115) 738 30.14 31.65 30.22 30.51 30.81 826 $ 298 (300) (104) 720 27.97 29.86 23.69 30.35 30.14 1,027 $ 318 (369) (150) 826 27.61 31.45 26.17 28.43 27.97 The total value of restricted stock vesting during the years ended December 31, 2013, 2012 and 2011, was $6.2 million, $7.1 million and $9.7 million. There were no SARs outstanding at December 31, 2013 and 2012. The following table summarizes the activity and terms of outstanding options at December 31, 2013, and for each of the years in the three-year period then ended: Number of Options (000’s) Weighted Average Exercise Price (per share) Weighted Average Remaining Contractual Life (years) Aggregate Intrinsic Value (millions) Options outstanding at December 31, 2010 Exercised Forfeited Options outstanding at December 31, 2011 Exercised Forfeited Options outstanding at December 31, 2012 Exercised Forfeited Options outstanding at December 31, 2013 $ 993 (432) (5) 556 (237) (7) 312 (244) (4) 64 21.30 20.74 23.50 21.72 21.04 21.07 22.25 21.97 21.72 23.33 43 0.7 $ 0.8 At December 31, 2013, the following stock option groups were outstanding: Range of Exercise Prices (per share) $17.01—22.00 $22.01—27.00 Options outstanding at December 31, 2013 Weighted Average Exercise Price (per share) Weighted Average Remaining Contractual Life (years) Number of Options (000’s) $ 15 49 64 20.49 24.21 23.33 1.8 0.4 0.7 The total intrinsic value of stock options exercised during the years ended December 31, 2013, 2012 and 2011, was $0.8 million, $1.9 million, and $4.9 million. No options were granted in 2013, 2012 or 2011. All options outstanding at December 31, 2013, were vested and exercisable. Note 13—Retirement Plans Savings and Retirement Plans. We maintain a voluntary 401(k) savings and retirement plan covering substantially all full-time and certain part-time employees in the United States who have completed one month of service and have attained age 18. We match a certain percentage of each employee’s contribution. The plan also provides for a minimum contribution by us to the plan for all eligible employees of 1% of their salary, subject to certain limits, and discretionary profit-sharing contributions. We may increase or decrease our matching contributions at our discretion, on a prospective basis. We incurred $10.1 million, $9.8 million, and $9.8 million of expense related to this plan in 2013, 2012 and 2011. We also maintain defined contribution plans in some of the European countries in which we operate. Expenses related to these plans were not material in 2013 and 2012. Domestic Retirement Plan. We have a noncontributory, unfunded retirement plan for certain officers and other key employees in the United States (Domestic Retirement Plan). In February 2012, our Board of Directors amended the Domestic Retirement Plan to freeze benefit levels and modify vesting provisions under the plan effective as of March 31, 2012. 44 The following table sets forth the Domestic Retirement Plan’s financial status and the amounts recognized in our consolidated balance sheets: December 31, Change in benefit obligation Benefit obligation, beginning of year Service cost Interest cost Actuarial (gain) loss Benefits paid Curtailment gain Benefit obligation, end of year Change in plan assets Fair value of plan assets, beginning of year Employer contribution Benefits paid Fair value of plan assets, end of year Funded status at December 31 Amounts recognized in the consolidated balance sheets Other current liabilities Other liabilities Accumulated other comprehensive loss Net amount recognized Accumulated benefit obligation Weighted average assumptions used to determine benefit obligation Discount rate Rate of increase in compensation levels 2013 2012 $ 46,759 $ 41,170 — 1,608 (4,700) (1,656) — 42,011 $ 130 1,616 6,125 (1,644) (638) 46,759 — $ — 1,656 (1,656) — $ $ (42,011) (1,831) $ (40,178) 10,849 (31,160) 42,011 $ $ 1,644 (1,644) — (46,759) (1,643) (45,115) 16,915 (29,843) 46,759 4.50% N/A 3.50% N/A $ $ $ $ $ $ $ Plan benefit obligations of the Domestic Retirement Plan were measured as of December 31, 2013 and 2012 and as of March 31, 2012. Plan benefit obligations are determined using assumptions developed at the measurement date. The weighted average discount rate, which is used to calculate the present value of plan liabilities, is an estimate of the interest rate at which the plan liabilities could be effectively settled at the measurement date. When estimating the discount rate, we review yields available on high-quality, fixed-income debt instruments and use a yield curve model from which the discount rate is derived by applying the projected benefit payments under the plan to points on a published yield curve. 45 The components of net periodic benefit cost for the Domestic Retirement Plan, which is included in selling, general, and administrative expenses in the consolidated statements of income, are as follows: Year ended December 31, Service cost Interest cost Amortization of prior service cost Recognized net actuarial loss Curtailment loss Net periodic benefit cost Weighted average assumptions used to determine net periodic benefit cost Discount rate Rate of increase in future compensation levels 2013 2012 2011 $ — $ 130 $ 1,608 — 1,366 — 1,616 — 971 234 1,302 1,805 293 582 — $ 2,974 $ 2,951 $ 3,982 3.50% N/A 4.00% 3.00% 5.20% 3.00% Amounts recognized for the Domestic Retirement Plan as a component of accumulated other comprehensive loss as of the end of the year that have not been recognized as a component of the net periodic benefit cost are presented in the following table. We expect to recognize approximately $0.8 million of the net actuarial loss reported in the following table as of December 31, 2013, as a component of net periodic benefit cost during 2014. Year ended December 31, Net actuarial loss Prior service cost Deferred tax benefit Amounts included in accumulated other comprehensive income (loss), net of tax 2013 2012 $ $ (10,848) $ — 4,231 (6,617) $ (16,915) — 6,597 (10,318) As of December 31, 2013, the expected benefit payments required for each of the next five years and the five-year period thereafter for the Domestic Retirement Plan are as follows: Year 2014 2015 2016 2017 2018 2019-2023 $ 1,872 1,987 2,097 2,193 2,295 13,308 International Retirement Plans. Certain of our foreign subsidiaries have defined benefit pension plans covering substantially all of their respective employees. As of December 31, 2013 and 2012, the accumulated benefit obligation under these plans was $2.4 million and $2.2 million. We recorded $0.2 million and $0.1 million in net periodic benefit cost in selling, general and administrative expenses for the years ended December 31, 2013 and 2012. Note 14—Income Taxes The components of income (loss) before income taxes consist of the following: Year ended December 31, Income (loss) before income taxes: U.S. Foreign Income before income taxes 2013 2012 2011 $ $ 192,239 (7,254) 184,985 $ $ 192,978 (9,622) 183,356 $ $ 189,833 — 189,833 46 The income tax provision consists of the following: Year ended December 31, Current tax provision (benefit): Federal State Foreign Total current tax provision Deferred tax provision (benefit): Federal State Foreign Total deferred tax provision Total income tax provision 2013 2012 2011 $ 58,487 $ 62,859 $ 10,455 1,448 70,390 5,455 394 (2,136) 3,713 10,537 (103) 73,293 2,529 438 (1,907) 1,060 $ 74,103 $ 74,353 $ 50,780 9,335 — 60,115 12,983 1,537 — 14,520 74,635 A reconciliation of the federal statutory rate to our effective income tax rate is shown below: Year ended December 31, Federal statutory rate Increases in the rate resulting from: State income taxes, net of federal income tax impact Foreign income taxes Other Effective income tax rate 2013 2012 2011 35.0% 35.0% 35.0% 3.9% 0.4% 0.8% 40.1% 3.9% 0.7% 1.0% 40.6% 3.7% —% 0.6% 39.3% 47 The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are presented below: December 31, Deferred tax assets: Employee benefit plans Accrued liabilities not currently deductible Finance charges Intangible assets Property and equipment Allowance for losses on accounts and notes receivable Net operating loss carryforwards Other Total deferred tax assets Less: valuation allowances Net deferred tax assets Deferred tax liabilities: Merchandise inventories Goodwill Property and equipment Computer software Insurance Intangible assets Employee benefit plans Other Total deferred tax liabilities Net deferred tax liability 2013 2012 $ 28,995 $ 13,591 6,316 2,171 1,507 3,922 8,643 2,083 67,228 (5,250) 61,978 69,994 33,455 18,026 11,400 1,070 4,523 103 585 30,138 17,610 7,042 2,749 1,593 3,885 5,540 1,901 70,458 (3,683) 66,775 70,916 31,020 18,110 10,576 1,030 5,266 188 1,309 139,156 (77,178) $ 138,415 (71,640) $ The valuation allowances relate to deferred tax assets in various state and non-U.S. jurisdictions. Based on management’s judgments using available evidence about historical and expected future taxable earnings, management believes it is more likely than not that we will realize the benefit of the existing deferred tax assets, net of valuation allowances, at December 31, 2013. The valuation allowances primarily relate to net operating loss carryforwards in non-U.S. jurisdictions which have various expiration dates ranging from five years to an unlimited carryforward period. There were no significant decreases in valuation allowances during 2013. It is our intention to permanently reinvest the earnings of our non-U.S. subsidiaries in those operations. As of December 31, 2013, we have not made a provision for U.S. or additional foreign withholding taxes on investments in foreign subsidiaries that are permanently reinvested, and there are no deferred tax liabilities that have not been provided. Cash payments for income taxes, including interest, for 2013, 2012, and 2011 were $65.4 million, $78.5 million, and $61.8 million. 48 At December 31, 2013 and 2012, the liability for unrecognized tax benefits was $4.6 million and $12.3 million. A reconciliation of the changes in unrecognized tax benefits from the beginning to the end of the reporting period is as follows: 2013 2012 Unrecognized tax benefits at January 1, Increases for positions taken during current period Increases for positions taken during prior periods Decreases for positions taken during prior periods Lapse of statute of limitations Settlements with taxing authorities Unrecognized tax benefits at December 31, $ 12,303 $ 758 333 (4,939) (3,580) (227) 4,648 $ 13,152 574 191 (432) (1,182) — $ 12,303 Included in the liability for unrecognized tax benefits at December 31, 2013 and 2012, were $3.4 million and $10.7 million of tax positions for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility. These tax positions are temporary differences which do not impact the annual effective tax rate under deferred tax accounting. Any change in the deductibility period of these tax positions would impact the timing of cash payments to taxing jurisdictions. Unrecognized tax benefits of $1.0 million and $1.7 million at December 31, 2013 and 2012, would impact our effective tax rate if recognized. We recognize accrued interest and penalties related to unrecognized tax benefits in income tax expense. Accrued interest at December 31, 2013 and 2012 was $0.1 million and $0.6 million. Interest income recognized during 2013 and 2012 was $0.4 million and $0.1 million. Interest expense recognized in 2011 was $0.2 million. There were no penalties accrued at December 31, 2013 or 2012 or recognized in 2013, 2012 and 2011. We file income tax returns in the U.S. federal and various state and foreign jurisdictions. Our U.S. federal income tax returns for the years 2011 and 2012 are subject to examination. In 2013 we concluded examinations of the 2009 and 2010 Federal returns and certain state income tax returns. Our income tax returns for U.S. state and local jurisdictions are generally open for the years 2010 through 2012; however, certain returns may be subject to examination for differing periods. The seller is contractually obligated to indemnify us for all income tax liabilities incurred by the Movianto business prior to our acquisition on August 31, 2012. Note 15—Net Income per Common Share The following table summarizes the calculation of net income per share attributable to common shareholders for the years ended December 31, 2013, 2012, and 2011. Year ended December 31, Numerator: Net income Less: income allocated to unvested restricted shares Net income attributable to common shareholders—basic Add: undistributed income attributable to unvested restricted shares—basic Less: undistributed income attributable to unvested restricted shares—diluted Net income attributable to common shareholders—diluted Denominator: Weighted average shares outstanding—basic Dilutive shares—stock options Weighted average shares outstanding—diluted Net income attributable to common shareholders: Basic Diluted 49 2013 2012 2011 $ $ $ $ $ 110,882 (738) 110,144 $ 109,003 (749) 108,254 115,198 (1,059) 114,139 257 292 480 (257) 110,144 $ (292) 108,254 $ (479) 114,140 62,625 36 62,661 62,765 79 62,844 1.76 1.76 $ $ 1.72 1.72 $ $ 62,756 168 62,924 1.82 1.81 Note 16—Shareholders’ Equity We have a shareholder rights agreement under which one Right is attendant to each outstanding share of our common stock. Each Right entitles the registered holder to purchase from us one fifteen-hundredth of a share of a Series A Participating Cumulative Preferred Stock (Series A Preferred Stock) at an exercise price of $66.67 (Purchase Price). The Rights will become exercisable, if not earlier redeemed, only if a person or group acquires more than 15% of the outstanding shares of our common stock, or if the Board of Directors so determines following the commencement of a public announcement of a tender or exchange offer, the consummation of which would result in ownership by a person or group of more than 15% of such outstanding shares. Each holder of a Right, upon the occurrence of certain events, will become entitled to receive, upon exercise and payment of the Purchase Price, Series A Preferred Stock (or in certain circumstances, cash, property or other securities of ours or a potential acquirer) having a value equal to twice the amount of the Purchase Price. The agreement is subject to review every three years by our independent directors. The Rights will expire on April 30, 2014, if not earlier redeemed. In February 2011, our Board of Directors authorized a share repurchase program of up to $50 million of our outstanding common stock to be executed at the discretion of management over a three-year period, expiring in February 2014. The program is intended to offset shares issued in conjunction with our stock incentive plan and may be suspended or discontinued at any time. During the year ended December 31, 2013, we repurchased in open-market transactions and retired approximately 0.6 million shares of our common stock for an aggregate of $18.9 million, or an average price per share of $33.72. As of December 31, 2013, we have no remaining shares available under the repurchase program. In February 2014, our Board of Directors renewed our share repurchase program authorizing the purchase of $100 million in common stock through 2017. The timing of repurchases and the exact number of shares of common stock to be repurchased will be determined by management based upon market conditions and other factors. The program is intended, in part, to offset shares issued in conjunction with our stock incentive plan and may be suspended or discontinued at any time. The noncontrolling interest in net income was not material in 2013, 2012 or 2011. Note 17 — Accumulated Other Comprehensive Income The following tables show the changes in accumulated other comprehensive income (loss) by component for the years ended December 31, 2013, 2012 and 2011: Retirement Plans Currency Translation Adjustments Other Total $ 163 — — $ (406) 11,156 (2,008) — (40) 32 (8) (8) 9,148 1,326 (500) 826 9,974 9,749 6,254 (111) 6,143 — — — 6,143 3,005 1,366 (532) 834 3,839 $ (6,479) $ 15,892 $ 155 $ 9,568 Accumulated other comprehensive income (loss), December 31, 2012 Other comprehensive income (loss) before reclassifications Income tax $ $ (10,318) 4,902 (1,897) Other comprehensive income before reclassifications, net of tax Amounts reclassified from accumulated other comprehensive income (loss) Income tax Amounts reclassified from accumulated other comprehensive income (loss), net of tax Other comprehensive income (loss) Accumulated other comprehensive income (loss), December 31, 2013 50 Accumulated other comprehensive income (loss), December 31, 2011 Other comprehensive income (loss) before reclassifications Income tax Other comprehensive income (loss) before reclassifications, net of tax Amounts reclassified from accumulated other comprehensive income (loss) Income tax Amounts reclassified from accumulated other comprehensive income (loss), net of tax Other comprehensive income (loss) Accumulated other comprehensive income (loss), December 31, 2012 Retirement Plans Currency Translation Adjustments Other Total $ $ (7,707) (5,487) 2,141 — $ 213 — — 9,959 (210) $ (7,494) 4,472 1,931 (3,346) 9,749 1,205 (470) 735 (2,611) — — — 9,749 — (82) 32 (50) (50) 6,403 1,123 (438) 685 7,088 $ (10,318) $ 9,749 $ 163 $ (406) Retirement Plans Currency Translation Adjustments Other Total Accumulated other comprehensive income (loss), December 31, 2010 $ Other comprehensive income (loss) before reclassifications Income tax Other comprehensive income (loss) before reclassifications, net of tax Amounts reclassified from accumulated other comprehensive income (loss) Income tax Amounts reclassified from accumulated other comprehensive income (loss), net of tax Other comprehensive income (loss) Accumulated other comprehensive income (loss), December 31, 2011 (5,379) (4,690) 1,829 (2,861) 874 (341) 533 (2,328) $ — $ 263 — — — — — — — — — (82) 32 (50) (50) $ (5,116) (4,690) 1,829 (2,861) 792 (309) 483 (2,378) $ (7,707) $ — $ 213 $ (7,494) We include amounts reclassified out of accumulated other comprehensive income related to defined benefit pension plans as a component of net periodic pension cost recorded in selling, general and administrative expenses. For the year ended December 31, 2013, we reclassified $1.4 million of actuarial net losses. For the year ended December 31, 2012 and 2011, we reclassified $1.0 million and $0.6 million of actuarial net losses and $0.2 million and $0.3 million of prior service costs. Note 18—Commitments and Contingencies We have a contractual commitment to outsource information technology operations, including the management and operation of our information technology systems and distributed services processing, as well as application support, development and enhancement services. This agreement was amended in November 2013 to extend the terms of service through October 2017, with two optional one year extensions. The commitment is cancelable with 180 days notice and payment of a termination fee based upon certain costs which would be incurred by the vendor as a direct result of the early termination. We pay scheduled fees under the agreement, which can vary based on changes in the Consumer Price Index and the level of support required. Assuming no early termination of the contract, our estimated remaining annual obligations under this agreement are $37.1 million in 2014, $36.7 million in 2015, $36.6 million in 2016, and $30.4 million in 2017. We paid $45.7 million, $52.5 million, and $48.4 million under this contract in 2013, 2012, and 2011. We have a contractual commitment to the partner in our joint venture in China to purchase a minimum dollar value of products in 2016. The maximum penalty which we would incur if we do not fulfill this commitment is $1.0 million. 51 We have entered into non-cancelable agreements to lease most of our office and warehouse facilities with remaining terms generally ranging from one to 20 years. Certain leases include renewal options, generally for five-year increments. We also lease most of our transportation and material handling equipment for terms generally ranging from three to ten years. At December 31, 2013, future minimum annual payments under non-cancelable lease agreements with original terms in excess of one year, and including payments required under operating leases for facilities we have vacated, are as follows: 2014 2015 2016 2017 2018 Thereafter Total minimum payments $ Total 60,056 51,691 43,564 34,604 30,557 76,075 $ 296,547 Rent expense for all operating leases for the years ended December 31, 2013, 2012, and 2011, was $76.7 million, $60.9 million, and $56.3 million. We have contractual obligations that are required to be paid to customers in the event that certain contractual performance targets are not achieved as of specified dates, generally within 36 months from inception of the contract. These contingent obligations totaled $2.3 million as of December 31, 2013. If none of the performance targets are met as of the specified dates, and customers have met their contractual commitments, payments will be due as follows: 2014—$1.1 million; 2015—$0.3 million; and 2016—$0.9 million. None of these contingent obligations were accrued at December 31, 2013, as we do not consider any of them probable. We deferred the recognition of fees that are contingent upon our future performance under the terms of these contracts. As of December 31, 2013, $0.9 million of deferred revenue related to outstanding contractual performance targets was included in other current liabilities. During the second quarter of 2013, we reached a settlement in the administrative proceedings pending before the California Board of Equalization related to certain municipal sales tax incentives. Under the terms of the settlement, we expect to receive approximately $4.3 million for the period January 1, 2009 through June 30, 2013, of which $0.8 million was recognized prior to 2013 as well as $0.8 million for the period from July 1 to December 31, 2013. In subsequent quarters, the company will receive an ongoing tax incentive that will vary with eligible revenues generated by sales to California-based customers. Prior to exiting the direct-to-consumer business in January 2009, we received reimbursements from Medicare, Medicaid, and private healthcare insurers for certain customer billings. We are subject to audits of these reimbursements for up to seven years from the date of the service. In connection with the Movianto acquisition, we entered into transition services agreements with the former owner under which it provides certain information technology and support services. The original contract terms ranged from six to 24 months and are cancelable without penalty with thirty days notice. As of December 31, 2013 these agreements were substantially complete. Various issues and potential claims related to the acquisition and transition of Movianto remain outstanding and under review and discussion with the former owner. The ultimate outcomes of these issues and potential claims, including their impact on future financial results, cannot be ascertained or estimated at this time. Note 19—Legal Proceedings We are subject to various legal actions that are ordinary and incidental to our business, including contract disputes, employment, workers’ compensation, product liability, regulatory and other matters. We have insurance coverage for employment, product liability, workers’ compensation and other personal injury litigation matters, subject to policy limits, applicable deductibles and insurer solvency. We establish reserves from time to time based upon periodic assessment of the potential outcomes of pending matters. Based on current knowledge and the advice of counsel, we believe that the accrual as of December 31, 2013 for currently pending matters considered probable of loss, which is not material, is sufficient. In addition, we believe that other currently pending matters are not reasonably likely to result in a material loss, as payment of the amounts claimed is remote, 52 the claims are insignificant, individually and in the aggregate, or the claims are expected to be adequately covered by insurance. Note 20—Segment Information We periodically evaluate our application of accounting guidance for reportable segments and disclose information about reportable segments based on the way management organizes the enterprise for making operating decisions and assessing performance. As a result of the August 31, 2012 acquisition of Movianto, we now report Movianto as a separate International business segment. Prior to the acquisition, we had one reportable business segment, which now comprises the Domestic segment. Accordingly, the Domestic segment now includes all services in the United States relating to our role as a medical supply logistics company serving healthcare providers and manufacturers. We evaluate the performance of our segments based on the operating earnings of our segments excluding acquisition-related and exit and realignment charges. The following tables present financial information by segment: Year ended December 31, Net revenue: Domestic International Consolidated net revenue Operating earnings (loss): Domestic International Acquisition-related and exit and realignment charges Consolidated operating earnings Depreciation and amortization: Domestic International Consolidated depreciation and amortization Capital expenditures: Domestic International Consolidated capital expenditures December 31, Total assets: Domestic International Segment assets Cash and cash equivalents Consolidated total assets 2013 2012 2011 $ $ $ $ $ $ $ $ 8,688,018 383,514 9,071,532 211,932 (1,405) (12,444) 198,083 35,808 14,778 50,586 42,802 17,327 60,129 $ $ $ $ $ $ $ $ 8,731,484 136,840 8,868,324 212,335 (5,418) (10,164) 196,753 35,016 4,588 39,604 34,450 4,513 38,963 $ $ $ $ $ $ $ $ 8,627,912 — 8,627,912 216,683 — (13,168) 203,515 34,135 — 34,135 36,315 — 36,315 2013 2012 $ 1,747,572 $ 1,730,396 474,565 2,222,137 101,905 386,114 2,116,510 97,888 $ 2,324,042 $ 2,214,398 The following tables present information by geographic area. Net revenues were attributed to geographic areas based on the locations from which we ship products or provide services. International operations consist of Movianto’s operations in the United Kingdom, Germany, France, and other European countries. 53 Year ended December 31, Net revenue: United States United Kingdom France Germany Other European countries Consolidated net revenue December 31, Long-lived assets: United States Germany United Kingdom France Other European countries Consolidated long-lived assets 2013 2012 2011 $ 8,688,018 $ 8,731,484 $ 8,627,912 211,296 52,725 42,807 76,686 86,332 14,338 13,670 22,500 — — — — $ 9,071,532 $ 8,868,324 $ 8,627,912 2013 2012 2011 $ 170,010 $ 162,333 $ 159,939 60,068 42,619 7,090 27,025 54,826 40,609 7,960 28,159 — — — — $ 306,812 $ 293,887 $ 159,939 Note 21—Condensed Consolidating Financial Information The following tables present condensed consolidating financial information for: Owens & Minor, Inc. (O&M); the guarantors of Owens & Minor, Inc.’s Senior Notes, on a combined basis; and the non-guarantor subsidiaries of the Senior Notes, on a combined basis. The guarantor subsidiaries are 100% owned by Owens & Minor, Inc. Separate financial statements of the guarantor subsidiaries are not presented because the guarantees by our guarantor subsidiaries are full and unconditional, as well as joint and several, and we believe the condensed consolidating financial information is more meaningful in understanding the financial position, results of operations and cash flows of the guarantor subsidiaries. Condensed Consolidating Financial Information Year ended December 31, 2013 Statements of Income Net revenue Cost of goods sold Gross margin Selling, general and administrative expenses Acquisition-related and exit and realignment charges Depreciation and amortization Other operating (income) expense, net Operating (loss) earnings Interest expense (income), net (Loss) income before income taxes Income tax (benefit) provision Equity in earnings of subsidiaries Net income (loss) Other comprehensive income (loss), net of tax Comprehensive income (loss) Owens & Minor, Inc. Guarantor Subsidiaries Non-guarantor Subsidiaries Eliminations Consolidated $ $ — $ — 8,687,131 7,826,768 $ — 2,559 — 14 — (2,573) 11,103 (13,676) (5,474) 119,084 110,882 9,974 120,856 54 $ 860,363 613,394 8,130 35,712 (4,290) 207,417 2,550 204,867 81,011 — 123,856 3,838 127,694 $ $ 435,035 177,541 257,494 247,703 (50,634) $ (49,852) (782) — 9,071,532 7,954,457 1,117,075 863,656 4,314 14,860 (3,404) (5,979) (555) (5,424) (1,434) — (3,990) 6,143 2,153 $ — — — (782) — (782) — (119,084) (119,866) (9,981) (129,847) $ 12,444 50,586 (7,694) 198,083 13,098 184,985 74,103 — 110,882 9,974 120,856 Condensed Consolidating Financial Information Year ended December 31, 2012 Statements of Income Net revenue Cost of goods sold Gross margin Selling, general and administrative expenses Acquisition-related and exit and realignment charges Depreciation and amortization Other operating expense (income), net Operating (loss) earnings Interest expense, net Income (loss) before income taxes Income tax (benefit) provision Equity in earnings of subsidiaries Net income (loss) Other comprehensive loss, net of tax Comprehensive income (loss) Year ended December 31, 2011 Statements of Income Net revenue Cost of goods sold Gross margin Selling, general and administrative expenses Acquisition-related and exit and realignment charges Depreciation and amortization Other operating (income) expense, net Operating (loss) earnings Interest expense, net Income (loss) before income taxes Income tax (benefit) provision Equity in earnings of subsidiaries Net income (loss) Other comprehensive income, net of tax Comprehensive income (loss) $ $ $ Owens & Minor, Inc. Guarantor Subsidiaries Non-guarantor Subsidiaries Eliminations Consolidated $ — $ 8,731,484 $ 165,188 $ — — 1,573 — 1 — (1,574) 16,677 (18,251) (7,121) 120,133 109,003 7,088 116,091 $ 7,885,030 846,454 599,046 (366) 34,944 (3,015) 215,845 (3,588) 219,433 85,157 — 134,276 (2,611) 131,665 $ 86,307 78,881 81,976 10,530 4,659 (1,447) (16,837) 308 (17,145) (3,683) — (13,462) 9,749 (3,713) $ (28,348) $ (27,667) (681) — 8,868,324 7,943,670 924,654 682,595 — — — (681) — (681) — (120,133) (120,814) (7,138) (127,952) $ 10,164 39,604 (4,462) 196,753 13,397 183,356 74,353 — 109,003 7,088 116,091 Owens & Minor, Inc. Guarantor Subsidiaries Non-guarantor Subsidiaries Eliminations Consolidated — $ 8,627,786 $ 126 $ — $ 8,627,912 — — 1,123 — — 677 (1,800) 9,749 (11,549) (4,538) 122,209 115,198 (2,378) 112,820 $ 7,770,359 857,427 608,905 13,168 34,135 (4,511) 205,730 3,855 201,875 79,320 — 122,555 (2,328) 120,227 $ 16 110 629 — — (104) (415) 78 (493) (147) — (346) — (346) $ — — — — — — — — — — (122,209) (122,209) 2,328 (119,881) $ 7,770,375 857,537 610,657 13,168 34,135 (3,938) 203,515 13,682 189,833 74,635 — 115,198 (2,378) 112,820 55 Condensed Consolidating Financial Information December 31, 2013 Balance Sheets Assets Current assets Cash and cash equivalents Accounts and notes receivable, net Merchandise inventories Other current assets Total current assets Property and equipment, net Goodwill, net Intangible assets, net Due from O&M and subsidiaries Advances to and investments in consolidated subsidiaries Other assets, net Total assets Liabilities and equity Current liabilities Accounts payable Accrued payroll and related liabilities Deferred income taxes Other current liabilities Total current liabilities Long-term debt, excluding current portion Due to O&M and subsidiaries Intercompany debt Deferred income taxes Other liabilities Total liabilities Equity Common stock Paid-in capital Retained earnings (deficit) Accumulated other comprehensive income (loss) Total Owens & Minor, Inc. shareholders’ equity Noncontrolling interest Total equity Owens & Minor, Inc. Guarantor Subsidiaries Non-guarantor Subsidiaries Eliminations Consolidated $ 74,391 $ 2,012 $ 25,502 $ — $ — — 201 496,310 750,999 72,049 74,592 1,321,370 2 — — — 1,533,294 408 96,500 247,271 17,881 377,786 — 63,848 79,722 22,128 207,058 334,410 95,459 28,168 22,525 — — 26,048 (3,178) (1,464) 202 (4,440) — — — (377,786) (1,533,294) — 101,905 572,854 771,663 279,510 1,725,932 191,961 275,439 40,406 — — 90,304 $ 1,608,296 $ 2,124,656 $ 506,610 $ (1,915,520) $ 2,324,042 $ — $ 595,865 $ 51,185 $ — — 6,811 6,811 204,028 373,544 — — — 584,383 126,193 196,605 691,547 12,792 41,464 87,795 737,916 7,228 — 138,890 32,173 47,816 964,023 — 242,024 925,184 10,504 149 185,792 247,630 2,559 2,910 — 11,554 4,462 269,115 1,500 259,864 (41,029) (3,178) $ — — — (3,178) — (376,454) (138,890) — — (518,522) (1,500) (501,888) (884,155) 643,872 23,296 41,613 280,398 989,179 213,815 — — 43,727 52,278 1,298,999 126,193 196,605 691,547 9,568 (6,575) 16,030 (9,455) 9,568 1,023,913 1,160,633 — — 1,023,913 1,160,633 236,365 1,130 237,495 506,610 (1,396,998) — (1,396,998) $ (1,915,520) $ 1,023,913 1,130 1,025,043 2,324,042 Total liabilities and equity $ 1,608,296 $ 2,124,656 $ 56 Condensed Consolidating Financial Information December 31, 2012 Balance Sheets Assets Current assets Cash and cash equivalents Accounts and notes receivable, net Merchandise inventories Other current assets Total current assets Property and equipment, net Goodwill, net Intangible assets, net Due from O&M and subsidiaries Advances to and investments in consolidated subsidiaries Other assets, net Total assets Liabilities and equity Current liabilities Accounts payable Accrued payroll and related liabilities Deferred income taxes Other current liabilities Total current liabilities Long-term debt, excluding current portion Due to O&M and subsidiaries Intercompany debt Deferred income taxes Other liabilities Total liabilities Equity Common stock Paid-in capital Retained earnings (deficit) Accumulated other comprehensive income (loss) Total Owens & Minor, Inc. shareholders’ equity Noncontrolling interest Total equity Owens & Minor, Inc. Guarantor Subsidiaries Non-guarantor Subsidiaries Eliminations Consolidated $ 58,190 $ 13,641 $ 26,057 $ — $ — — 1,627 59,817 16 — — — 1,434,186 6,885 474,533 750,046 76,036 1,314,256 95,516 247,271 19,972 236,612 — 55,781 66,049 14,391 155,109 261,606 96,309 27,613 22,341 34,248 — 19,586 (3,247) (681) (1,508) (5,436) — — — (270,860) (1,434,186) (7,135) 97,888 537,335 763,756 231,264 1,630,243 191,841 274,884 42,313 — — 75,117 $ 1,500,904 $ 1,969,408 $ 461,703 $ (1,717,617) $ 2,214,398 $ 45,300 $ 518,545 $ 42,542 $ — — 6,464 51,764 205,754 270,860 — — — 528,378 126,544 187,394 658,994 18,201 43,110 92,318 672,174 6,592 — 138,890 30,141 58,578 906,375 — 242,024 831,327 7,267 1,349 156,142 207,300 3,037 — — 12,417 4,876 227,630 (3,250) $ — (2,352) — (5,602) — (270,860) (138,890) (6,289) — (421,641) 1,500 258,635 (36,941) (1,500) (500,659) (794,386) 603,137 25,468 42,107 254,924 925,636 215,383 — — 36,269 63,454 1,240,742 126,544 187,394 658,994 (406) (10,318) 9,749 569 (406) 972,526 1,063,033 — — 972,526 1,063,033 232,943 1,130 234,073 461,703 (1,295,976) — (1,295,976) $ (1,717,617) $ 972,526 1,130 973,656 2,214,398 Total liabilities and equity $ 1,500,904 $ 1,969,408 $ 57 Year ended December 31, 2013 Statements of Cash Flows Operating activities: Net income (loss) Adjustments to reconcile net income to cash provided by (used for) operating activities: Equity in earnings of subsidiaries Depreciation and amortization Share-based compensation expense Deferred income tax (benefit) expense Provision for losses on accounts and notes receivable Changes in operating assets and liabilities: Accounts and notes receivable Merchandise inventories Accounts payable Net change in other assets and liabilities Other, net Cash provided by (used for) operating activities Investing activities: Additions to computer software and intangible assets Additions to property and equipment Proceeds from sale of property and equipment Cash used for investing activities Financing activities: Change in intercompany advances Cash dividends paid Repurchases of common stock Proceeds from exercise of stock options Excess tax benefits related to share-based compensation Other, net Cash provided by (used for) financing activities Effect of exchange rate changes on cash and cash equivalents Net increase (decrease) in cash and cash equivalents Cash and cash equivalents at beginning of year Cash and cash equivalents at end of year Condensed Consolidating Financial Information Owens & Minor, Inc. Guarantor Subsidiaries Non-guarantor Subsidiaries Eliminations Consolidated $ 110,882 $ 123,856 $ (3,990) $ (119,866) $ 110,882 — 119,084 (119,084) 14 — — — — — (45,300) 1,774 (1,541) — 35,712 6,381 5,821 14,860 — (2,108) 278 509 (22,055) (170) 77,320 (12,068) 515 (16,522) (7,676) 15,286 (22,043) (97) (53,255) 215,590 (21,781) — — — — 145,354 (60,731) (18,876) 5,352 898 (2,541) (21,773) (21,029) 2,746 (40,056) (184,092) — — — (10,237) (7,090) 305 (17,022) 38,738 — — — — (3,071) — (3,011) 69,456 (187,163) 35,727 — — 2,521 16,201 (11,629) (555) 58,190 13,641 26,057 — — — — (68) 782 68 — — — — — — — — — — — — — — — — — — 50,586 6,381 3,713 787 (38,645) (7,064) 47,374 (32,337) (1,123) 140,554 (32,010) (28,119) 3,051 (57,078) — (60,731) (18,876) 5,352 898 (8,623) (81,980) 2,521 4,017 97,888 $ 74,391 $ 2,012 $ 25,502 $ — $ 101,905 58 Year ended December 31, 2012 Statements of Cash Flows Operating activities: Net income (loss) Adjustments to reconcile net income to cash provided by (used for) operating activities: Equity in earnings of subsidiaries Depreciation and amortization Deferred income tax expense Share-based compensation expense Provision for losses on accounts and notes receivable Changes in operating assets and liabilities: Accounts and notes receivable Merchandise inventories Accounts payable Net change in other assets and liabilities Other, net Cash provided by (used for) operating activities Investing activities: Acquisition, net of cash acquired Additions to property and equipment Additions to computer software and intangible assets Proceeds from sale of property and equipment Cash used for investing activities Financing activities: Change in intercompany advances Cash dividends paid Repurchases of common stock Financing costs paid Excess tax benefits related to share-based compensation Proceeds from exercise of stock options Other, net Cash provided by (used for) financing activities Effect of exchange rate changes on cash and cash equivalents Net increase (decrease) in cash and cash equivalents Cash and cash equivalents at beginning of year Cash and cash equivalents at end of year Condensed Consolidating Financial Information Owens & Minor, Inc. Guarantor Subsidiaries Non-guarantor Subsidiaries Eliminations Consolidated $ 109,003 $ 134,276 $ (13,462) $ (120,814) $ 109,003 — 120,133 (120,133) 1 — — — — — (67,800) 19 (1,738) — 34,944 2,933 5,697 4,659 (1,873) — 587 417 31,513 56,235 55,941 (2,653) 1,236 (7,599) 1,818 (3,585) (1,859) (71) (80,648) 320,709 (21,555) — — — — — 86,131 (55,681) (15,000) — 1,293 4,986 (2,901) — (4,249) (27,960) 1,057 (155,210) (5,583) (1,171) 2,241 (31,152) (159,723) (287,200) — — (1,303) — — (2,222) 201,069 — — — — — 2,413 18,828 (290,725) 203,482 — — 2,734 (61,820) (1,168) 24,938 120,010 14,809 1,119 — — — — 3,247 681 (3,250) 3 — — — — — — — — — — — — — — — — — — — 39,604 1,060 5,697 1,004 27,161 58,734 (18,694) (4,490) (573) 218,506 (155,210) (9,832) (29,131) 3,298 (190,875) — (55,681) (15,000) (1,303) 1,293 4,986 (2,710) (68,415) 2,734 (38,050) 135,938 97,888 $ 58,190 $ 13,641 $ 26,057 $ — $ 59 Year ended December 31, 2011 Statements of Cash Flows Operating activities: Net income (loss) Adjustments to reconcile net income to cash (used for) provided by operating activities: Equity in earnings of subsidiaries Depreciation and amortization Deferred income tax benefit Share-based compensation expense Provision for losses on accounts and notes receivable Pension contributions Changes in operating assets and liabilities: Accounts and notes receivable Merchandise inventories Accounts payable Net change in other assets and liabilities Other, net Cash provided by (used for) operating activities of continuing operations Investing activities: Additions to property and equipment Additions to computer software and intangible assets Proceeds from sale of property and equipment Cash used for investing activities of continuing operations Financing activities: Change in intercompany advances Cash dividends paid Repurchases of common stock Proceeds from termination of interest rate swaps Excess tax benefits related to share-based compensation Proceeds from exercise of stock options Other, net Cash provided by (used for) financing activities of continuing operations Discontinued operations: Operating cash flows Net cash used for discontinued operations Net increase (decrease) in cash and cash equivalents Cash and cash equivalents at beginning of year Cash and cash equivalents at end of year Condensed Consolidating Financial Information Owens & Minor, Inc. Guarantor Subsidiaries Non-guarantor Subsidiaries Eliminations Consolidated $ 115,198 $ 122,555 $ (346) $ (122,209) $ 115,198 — — — — — — (125) (85) 86 145 (97) (422) (183) (137) — (320) (122,209) — — — — — 313 — 113,100 539 (998) — 34,135 14,520 5,674 2,176 (409) (37,461) (86,165) (69,128) (25,338) 2,339 105,943 (37,102) — — — — (87,415) (50,909) (16,124) 4,005 2,154 9,179 (3,720) (24,798) (11,197) 2,430 (33,565) 85,276 2,139 — — — — — (2,116) — — — — — — (142,830) 83,160 2,139 — — — — (278) (278) (36,887) 12,493 1,119 156,897 2,316 — 122,209 — — — — — — — — — — — — — — — — — — — — — — — — — — — $ 120,010 $ 14,809 $ 1,119 $ — $ 60 — 34,135 14,520 5,674 2,176 (409) (37,273) (86,250) 44,058 (24,654) 1,244 68,419 (24,981) (11,334) 2,430 (33,885) — (50,909) (16,124) 4,005 2,154 9,179 (5,836) (57,531) (278) (278) (23,275) 159,213 135,938 Report of Independent Registered Public Accounting Firm The Board of Directors and Shareholders Owens & Minor, Inc.: We have audited the accompanying consolidated balance sheets of Owens & Minor, Inc. and subsidiaries as of December 31, 2013 and 2012, and the related consolidated statements of income, comprehensive income, changes in shareholders’ equity, and cash flows for each of the years in the period ended December 31, 2013. These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion. In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Owens & Minor, Inc. and subsidiaries as of December 31, 2013 and 2012, and the results of their operations and their cash flows for each of the years in the period ended December 31, 2013, in conformity with U.S. generally accepted accounting principles. We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), Owens & Minor, Inc.’s internal control over financial reporting as of December 31, 2013, based on criteria established in Internal Control - Integrated Framework (1992) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO), and our report dated February 24, 2014, expressed an unqualified opinion on the effectiveness of the Company’s internal control over financial reporting. Richmond, Virginia February 24, 2014 61 SELECTED QUARTERLY FINANCIAL INFORMATION (unaudited) (in thousands, except per share data) Net revenue (3) Gross margin Net income Net income attributable to Owens & Minor, Inc. per common share: Basic Diluted Cash dividends per common share Market price: High Low (in thousands, except per share data) Net revenue (3) Gross margin Net income Net income attributable to Owens & Minor, Inc. per common share: Basic Diluted Cash dividends per common share Market price: High Low Year Ended December 31, 2013 (1) 1st Quarter 2nd Quarter 3rd Quarter 4th Quarter $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ 2,246,384 279,052 26,098 0.41 0.41 0.24 32.56 29.17 $ $ $ $ $ $ $ $ 2,236,077 273,431 28,872 0.46 0.46 0.24 35.43 30.12 $ $ $ $ $ $ $ $ 2,270,547 273,329 27,970 0.44 0.44 0.24 36.26 33.50 Year Ended December 31, 2012 (2) 1st Quarter 2,217,882 214,328 29,360 0.46 0.46 0.22 31.28 27.59 2nd Quarter 2,185,444 211,429 30,113 0.48 0.48 0.22 30.63 27.64 $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ 3rd Quarter 2,170,790 228,123 24,597 0.39 0.39 0.22 31.10 27.81 $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ 2,318,524 291,263 27,942 0.44 0.44 0.24 38.23 33.95 4th Quarter 2,294,208 270,774 24,934 0.40 0.39 0.22 30.27 27.01 _____________________________ (1) We incurred charges of $2.0 million ($1.5 million after tax, or $0.03 per diluted common share) in the first quarter of 2013, $0.6 million ($0.4 million after tax) in the second quarter of 2013, $2.7 million ($1.9 million after tax, or $0.03 per diluted common share) in the third quarter of 2013, and $7.0 million ($5.0 million after tax, or $0.08 per diluted common share) in the fourth quarter of 2013 associated with acquisition-related and exit and realignment activities. (2) (3) We incurred charges of $0.6 million ($0.4 million after tax) in the second quarter of 2012, $7.8 million ($6.6 million after tax, or $0.10 per diluted common share) in the third quarter of 2012 and $1.7 million ($1.2 million after tax, or $0.02 per diluted common share) in the fourth quarter of 2012 associated with acquisition-related and exit and realignment activities. The first three quarters of 2013 and the third and fourth quarter of 2012 have been revised to reflect current revenue presentation. See Note 1 of Notes to Consolidated Financial Statements. 62 3.1 3.2 4.1 4.2 4.3 10.1 10.2 10.3 10.4 10.5 10.6 10.7 10.8 10.9 Index to Exhibits Amended and Restated Articles of Incorporation of Owens & Minor, Inc. (incorporated herein by reference to our Current Report on Form 8-K, Exhibit 3.1, dated July 29, 2008) Amended and Restated Bylaws of Owens & Minor, Inc. (incorporated herein by reference to our Current Report on Form 8-K, Exhibit 3.1, dated November 5, 2013) Indenture, dated as of April 7, 2006, for the Senior Notes due 2016 among the Company, Owens & Minor Distribution, Inc., Owens & Minor Medical, Inc., Owens & Minor Healthcare Supply, Inc., Access Diabetic Supply, LLC and SunTrust Bank, as trustee (incorporated herein by reference to the Company’s Current Report on Form 8-K, Exhibit 4.2, dated April 7, 2006) Form of Global Security for the Senior Notes due 2016 (incorporated herein by reference to the Company’s Current Report on Form 8-K, Exhibit 4.3, dated April 7, 2006) Rights Agreement dated as of April 30, 2004, between Owens & Minor, Inc., and Bank of New York, as Rights Agent (incorporated herein by reference to the Company’s Annual Report on Form 10-K, Exhibit 4.6, for the year ended December 31, 2003) Owens & Minor, Inc. 2003 Directors’ Compensation Plan (incorporated herein by reference to Annex B of the Company’s definitive Proxy Statement filed pursuant to Section 14(a) of the Securities Exchange Act on March 13, 2003 (File No. 001-09810))* Amendment to 2003 Directors’ Compensation Plan (incorporated herein by reference to the Company’s Quarterly Report on Form 10-Q, Exhibit 10.6, for the quarter ended March 31, 2008)* Form of Director Restricted Stock Grant Agreement (incorporated herein by reference to the Company’s Quarterly Report on Form 10-Q, Exhibit 10.3, for the quarter ended March 31, 2008)* Owens & Minor, Inc. Directors’ Deferred Compensation Plan, as amended and restated effective January 1, 2005 (incorporated herein by reference to the Company’s Quarterly Report on Form 10-Q, Exhibit 10.3, for the quarter ended September 30, 2008)* Deferral Election Form for The Owens & Minor, Inc. Directors’ Deferred Compensation Plan (incorporated by reference to the Company’s Annual Report on Form 10-K, Exhibit 10.9 for the year ended December 31, 2010)* Form of Owens & Minor, Inc. Executive Severance Agreement effective January 1, 2011 (incorporated by reference to the Company’s Annual Report on Form 10-K, Exhibit 10.10 for the year ended December 31, 2010)* Owens & Minor, Inc. Supplemental Executive Retirement Plan, as amended and restated effective January 1, 2005 (“SERP”) (incorporated herein by reference to the Company’s Quarterly Report on Form 10-Q, Exhibit 10.1, for the quarter ended September 30, 2008)* Resolutions of the Board of Directors of the Company amending the SERP (incorporated by reference to the Company’s Annual Report on Form 10-K, Exhibit 10.12 for the year ended December 31, 2011)* Owens & Minor, Inc. Amended and Restated Management Equity Ownership Program and Stock Ownership Rewards Program (incorporated by reference to the Company’s Annual Report on Form 10-K, Exhibit 10.15, for the year ended December 31, 2009)* 10.10 Amendment to MEOP effective January 1, 2014*--filed herewith 10.11 10.12 Owens & Minor, Inc. Executive Deferred Compensation and Retirement Plan effective January 1, 2013 (incorporated by reference to the Company’s Quarterly Report on Form 10-Q Exhibit 10.1 for the quarter ended March 31, 2013)* Owens & Minor, Inc. Pension Plan, as amended and restated effective January 1, 1994 (“Pension Plan”) (incorporated herein by reference to the Company’s Annual Report on Form 10-K, Exhibit 10(c), for the year ended December 31, 1996)* 63 10.13 10.14 10.15 10.16 10.17 10.18 10.19 10.20 10.21 10.22 10.23 10.24 10.25 10.26 10.27 10.28 10.29 10.30 Amendment No. 1 to Pension Plan (incorporated herein by reference to the Company’s Annual Report on Form 10-K, Exhibit 10(d), for the year ended December 31, 1996)* Amendment No. 2 to Pension Plan (incorporated herein by reference to the Company’s Annual Report on Form 10-K, Exhibit 10.5, for the year ended December 31, 1998)* Resolutions of the Board of Directors of the Company amending the Owens & Minor, Inc. Pension Plan. (incorporated herein by reference to the Company’s Current Report on Form 8-K, Exhibit 10.5, dated May 3, 2006)* Amendment No. 3 to Pension Plan (incorporated herein by reference to the Company’s Quarterly Report on Form 10-Q, Exhibit 10.2, for the quarter ended September 30, 2008)* Fourth Amendment to Pension Plan (incorporated herein by reference to the Company’s Annual Report on Form 10-K, Exhibit 10.24, for the year ended December 31, 2009)* Fifth, Sixth, and Seventh Amendments to Pension Plan (incorporated by reference to the Company’s Annual Report on Form 10-K, Exhibit 10.22 for the year ended December 31, 2010)* Owens & Minor, Inc. 2005 Stock Incentive Plan, as amended (incorporated herein by reference to the Company’s Registration Statement on Form S-8, Registration No. 333-124965)* Resolution of the Board of Directors of the Company amending the Owens & Minor, Inc. 2005 Stock Incentive Plan (incorporated herein by reference to the Company’s Annual Report on Form 10-K, Exhibit 10.21, for the year ended December 31, 2007)* Amendment to Owens & Minor, Inc. 2005 Stock Incentive Plan (incorporated herein by reference to the Company’s Quarterly Report on Form 10-Q, Exhibit 10.4, for the quarter ended March 31, 2008)* Amendment to Owens & Minor, Inc. 2005 Stock Incentive Plan (incorporated herein by reference to the Company’s definitive Proxy Statement filed pursuant to Section 14(a) of the Securities Exchange Act on March 17, 2010 (File No. 001-09810))* Form of Owens & Minor, Inc. Stock Option Grant Agreement under 2005 Stock Incentive Plan (incorporated herein by reference to the company’s Current Report on Form 8-K, Exhibit 10.1, dated June 23, 2005)* Form of Owens & Minor, Inc. Restricted Stock Grant Agreement under 2005 Stock Incentive Plan (incorporated herein by reference to the Company’s Quarterly Report on Form 10-Q, Exhibit 10.2, for the quarter ended March 31, 2008)* Form of Performance Share Award Agreement (incorporated by reference to the Company’s Annual Report on Form 10-K, Exhibit 10.31 for the year ended December 31, 2012) * Form of Performance Share Award Agreement *--filed herewith Form of Annual Executive Incentive Program (incorporated by reference to the Company’s Annual Report on Form 10-K, Exhibit 10.32 for the year ended December 31, 2012) * Owens & Minor, Inc. Officer Severance Policy Terms (incorporated herein by reference to the Company’s Current Report on Form 8-K, Exhibit 10.1, dated December 19, 2005)* Policy on Recoupment of Executive Incentive Compensation (incorporated herein by reference to the Company’s Annual Report on Form 10-K, Exhibit 10.36, for the year ended December 31, 2009)* Credit Agreement dated as of June 5, 2012 by and among Owens & Minor Distribution, Inc., and Owens & Minor Medical, Inc. (as Borrowers), Owens & Minor, Inc. and certain of its domestic subsidiaries (as Guarantors), Wells Fargo Bank, N.A. (as Administrative Agent), JPMorgan Chase Bank, N.A. (as Syndication Agent) and a syndicate of banks as specified on the signature pages thereof (incorporated herein by reference to the Company’s Current Report on Form 8-K, Exhibit 10.1, dated June 8, 2012) 64 10.31 11.1 21.1 23.1 31.1 31.2 32.1 32.2 Share Purchase Agreement dated August 31, 2012 between Celesio AG, Admenta Deutschland GmbH, Admenta Denmark ApS, Admenta France S.A. and OCP Portugal Produtos Farmaceuticos, S.A. (as Sellers) and O&M-Movianto Nederland B.V., O&M-Movianto UK Holdings Ltd, O&M-Movianto France Holdings SAS (as Purchasers) and Owens & Minor, Inc. (as Purchasers’ Guarantor) (incorporated herein by reference to our Current Report on Form 8-K, Exhibit10.1, dated September 4, 2012) Calculation of Net Income per Common Share. Information related to this item is in Part II, Item 8, Notes to Consolidated Financial Statements, Note 15-Net Income per Common Share Subsidiaries of Registrant Consent of KPMG LLP, independent registered public accounting firm Certification of Chief Executive Officer pursuant to Rule 13(a)-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 Certification of Chief Financial Officer pursuant to Rule 13(a)-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 101.INS XBRL Instance Document 101.SCH XBRL Taxonomy Extension Schema Document 101.CAL XBRL Taxonomy Extension Calculation Linkbase Document 101.DEF XBRL Taxonomy Definition Linkbase Document 101.LAB XBRL Taxonomy Extension Label Linkbase Document 101.PRE XBRL Taxonomy Extension Presentation Linkbase Document * Management contract or compensatory plan or arrangement. 65 Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on the 24th day of February, 2014. SIGNATURES OWENS & MINOR, INC. /s/ Craig R. Smith Craig R. Smith Chairman & Chief Executive Officer Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated on the 24th day of February, 2014: /s/ Martha H. Marsh Martha H. Marsh Director /s/ Eddie N. Moore, Jr. Eddie N. Moore, Jr. Director /s/ James E. Rogers James E. Rogers Lead Director /s/ David S. Simmons David S. Simmons Director /s/ Robert C. Sledd Robert C. Sledd Director /s/ Anne Marie Whittemore Anne Marie Whittemore Director /s/ Craig R. Smith Craig R. Smith Chairman & Chief Executive Officer /s/ Richard A. Meier Richard A. Meier Executive Vice President & Chief Financial Officer /s/ Stuart M. Essig Stuart M. Essig Director /s/ Richard E. Fogg Richard E. Fogg Director /s/ John W. Gerdelman John W. Gerdelman Director /s/ Lemuel E. Lewis Lemuel E. Lewis Director 66 Corporate Officers Craig R. Smith (62) Chairman & Chief Executive Officer Chairman of the Board since April 2013 and Chief Executive Officer since 2005. Mr. Smith also served as President from 1999 until August 2013. Mr. Smith has been with the company since 1989. James L. Bierman (61) President & Chief Operating Officer President since August 2013 and Chief Operating Officer since March 2012. Previously, Mr. Bierman served as Executive Vice President & Chief Operating Officer from March 2012 until August 2013. Mr. Bierman served as Executive Vice President & Chief Financial Officer from April 2011 to March 2012. Prior to that, Mr. Bierman served as Senior Vice President & Chief Financial Officer from 2007 to 2011. Mr. Bierman joined the company in 2007. Richard A. Meier (54) Executive Vice President & Chief Financial Officer Executive Vice President & Chief Financial Officer since joining Owens & Minor in March 2013. Mr. Meier served from 2010 to 2012 as Executive Vice President & Chief Financial Officer of Teleflex, Inc., a global provider of specialty medical devices. Prior to that, he served as President & Chief Operating Officer of Advanced Medical Optics, Inc., from 2007 to 2009, and as Chief Financial Officer and in a variety of other finance and operations roles from 2002 through 2007. Charles C. Colpo (56) Senior Vice President, Strategic Relationships Senior Vice President, Strategic Relationships since August 2013. From March 2012 until August 2013, Mr. Colpo served as Senior Vice President, Operations. Prior to that, Mr. Colpo served as Executive Vice President & Chief Operating Officer from 2010 to 2012. Mr. Colpo served as Executive Vice President, Administration from 2008 until 2010 and as Senior Vice President, Operations, from 1999 until 2008. He has been with the company since 1981. Erika T. Davis (50) Senior Vice President, Administration & Operations Senior Vice President, Administration & Operations since August 2013. Prior to that, Ms. Davis served as Senior Vice President, Human Resources, from 2001 until August 2013. Ms. Davis has been with the company since 1993. Grace R. den Hartog (62) Senior Vice President, General Counsel & Corporate Secretary Senior Vice President, General Counsel & Corporate Secretary since joining Owens & Minor in 2003. Previously, Ms. den Hartog served as a partner of McGuireWoods LLP from 1990 to 2003. D. Todd Healy (51) Senior Vice President, Provider Services Senior Vice President, Provider Services since August 2013. Prior to that, Mr. Healy served as Regional Vice President, North Region from 2004 to August 2013. He has served in general manager, division vice president and area vice president positions since joining Owens & Minor in 1994. 67 Richard W. Mears (53) Senior Vice President, Chief Information Officer Senior Vice President, Chief Information Officer since joining Owens & Minor in 2005. Previously, Mr. Mears was an Executive Director with Perot Systems (now Dell Perot Systems) from 2003 to 2005. Brian J. Shotto (50) Senior Vice President, Manufacturer Services Senior Vice President, Manufacturer Services since August 2013. Previously, Mr. Shotto served as Senior Vice President, Specialty Services from October 2011 until August 2013. Mr. Shotto served as a Principal Consultant for the Blue Fin Group from 2009 until 2011. Prior to that, he served as Vice President, Distribution Strategy - Healthcare Logistics Strategy Group, UPS, from 2006 to 2009, a company he joined in 2000. Mr. Shotto joined Owens & Minor in 2011. Mark A. Van Sumeren (56) Senior Vice President, Strategy & Business Development Senior Vice President, Strategy & Business Development since 2009 and Senior Vice President, Business Development, from 2007 to 2009. Prior to that, Mr. Van Sumeren was Senior Vice President, OMSolutionsSM from 2003 to 2006. Mr. Van Sumeren served as Vice President for Cap Gemini Ernst & Young from 2000 to 2003. He has been with the company since 2003. Numbers inside parentheses indicate age. 68 Subsidiaries of Registrant Exhibit 21.1 Subsidiary Owens & Minor Medical, Inc. O&M Funding Corp. Owens & Minor Distribution, Inc. OM Solutions International, Inc. Owens & Minor Canada, Inc. Owens & Minor Global Resources, LLC Owens & Minor Healthcare Supply, Inc. Access Diabetic Supply, LLC Access Respiratory Supply, Inc. Medical Supply Group, Inc. Key Diabetes Supply Co. OMI International, Ltd. Mira MEDsource Holding Company Limited Mira MEDsource (Shanghai) Company Limited Owens & Minor International Logistics, Inc. O&M Worldwide, LLC GNB Associates LLC Rutherford Holdings CV Lockwood Enterprises CV O&M-Movianto Nederland B.V. O&M-Movianto UK Holdings Ltd. O&M-Movianto France Holdings S.A.S. Movianto Belgium NV Movianto Ceska republika sro Movianto Nordic Aps Movianto France SAS Movianto GmbH Movianto Deutschland GmbH Movianto Portugal SL Movianto Slovensko sro AVS Health Espana SL Movianto Espana SL Movianto Schweiz GmbH Healthcare Services Group Ltd Movianto UK Ltd. Movianto Transport Solutions Ltd. Healthcare Product Services Ltd. Pharmacare Logistics Ltd. State of Incorporation/ Organization Virginia Virginia Virginia Virginia Virginia Virginia Virginia Florida Florida Virginia Michigan N/A N/A N/A Virginia Virginia Virginia N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 69 Assumed Name OM HealthCare Logistics AOM HealthCare Solutions AOM HealthCare Solutions Country USA USA USA USA USA USA USA USA USA USA USA British Virgin Islands Hong Kong Peoples Republic of China USA USA USA Netherlands Netherlands Netherlands United Kingdom France Belgium Czech Republic Denmark France Germany Germany Portugal Slovakia Spain Spain Switzerland United Kingdom United Kingdom United Kingdom United Kingdom United Kingdom Consent of Independent Registered Public Accounting Firm Exhibit 23.1 The Board of Directors Owens & Minor, Inc.: We consent to the incorporation by reference in the registration statements (Nos. 33-32497, 33-41402, 333-106361, 333-124965, and 333-142716) on Form S-8 of Owens & Minor, Inc. of our report dated February 24, 2014, with respect to the consolidated balance sheets of Owens & Minor, Inc. and subsidiaries as of December 31, 2013 and 2012, and the related consolidated statements of income, comprehensive income, changes in shareholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2013, and the effectiveness of internal control over financial reporting as of December 31, 2013, which reports appear in the December 31, 2013 annual report on Form 10-K of Owens & Minor, Inc. Richmond, Virginia February 24, 2014 70 CERTIFICATION PURSUANT TO RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 Exhibit 31.1 I, Craig R. Smith, certify that: 1. I have reviewed this Annual Report on Form 10-K for the year ended December 31, 2013, of Owens & Minor, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and significant role in the registrant’s internal control over financial reporting. b) Any fraud, whether or not material, that involves management or other employees who have a Date: February 24, 2014 /s/ Craig R. Smith Craig R. Smith Chairman & Chief Executive Officer Owens & Minor, Inc. 71 CERTIFICATION PURSUANT TO RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 Exhibit 31.2 I, Richard A. Meier, certify that: 1. I have reviewed this Annual Report on Form 10-K for the year ended December 31, 2013, of Owens & Minor, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and significant role in the registrant’s internal control over financial reporting. b) Any fraud, whether or not material, that involves management or other employees who have a Date: February 24, 2014 /s/ Richard A. Meier Richard A. Meier Executive Vice President & Chief Financial Officer Owens & Minor, Inc. 72 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Exhibit 32.1 In connection with the Annual Report of Owens & Minor, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2013, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Craig R. Smith, Chairman & Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge: (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. /s/ Craig R. Smith Craig R. Smith Chairman & Chief Executive Officer Owens & Minor, Inc. February 24, 2014 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Exhibit 32.2 In connection with the Annual Report of Owens & Minor, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2013, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Richard A. Meier, Executive Vice President & Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge: (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. /s/ Richard A. Meier Richard A. Meier Executive Vice President & Chief Financial Officer Owens & Minor, Inc. February 24, 2014 73 THIS PAGE DOES NOT PRINT. HOLDING PAGE FOR THE BACK OF THE 10-K CORPORATE INFORmATION Annual Shareholders’ meeting The annual meeting of Owens & Minor, Inc.’s shareholders will be held at 10:00 a.m. on Thursday, May 1, 2014, at Owens & Minor, Inc., 9120 Lockwood Boulevard, Mechanicsville, Virginia, 23116; 804-723-7000. Transfer Agent, Registrar and Dividend Disbursing Agent Computershare Shareowner Services P.O. Box 30170 College Station, TX 77842-3170 Website: www.computershare.com/investor Toll-free: 866-252-0358 (Inside the United States and Canada) 201-680-6578 (Outside the United States and Canada) Stock Purchase and Dividend Reinvestment Plan Our transfer agent, Computershare Shareowner Services (“Computershare”), offers a Direct Purchase & Sale Plan for shares of Owens & Minor, Inc. common stock known as the Computershare CIP Plan (“CIP Plan”). The CIP Plan offers registered shareholders of Owens & Minor and interested first- time investors a convenient way to buy, hold and sell shares of Owens & Minor common stock. Information may be obtained through the “Buy Stock Direct” link at www.computershare. com/investor, or by contacting Computershare (see contact information above). Shareholder Records Correspondence concerning stock holdings, lost or missing dividend checks, or changes of address for shares of Owens & Minor, Inc’s. common stock should be directed to Computershare at the address below: Owens & Minor, Inc. c/o Computershare P.O. Box 30170 College Station, TX 77842-3170 Duplicate mailings When a shareholder owns shares in more than one account, or when several shareholders live at the same address, they may receive multiple copies of company mailings. To eliminate duplicate mailings, please call Computershare or consider enrolling in electronic delivery (via Computershare’s website above), which offers secure online access to financial documents and shareholder communications. Independent Auditors KPMG LLP Richmond, Virginia Communications & Investor Relations Press Releases Owens & Minor, Inc.’s press releases are available at www.owens-minor.com Investor Relations 804-723-7555 Information for Investors The company files annual, quarterly and current reports, information statements and other information with the Securities and Exchange Commission (SEC). The public may read and copy any materials that the company files with the SEC at the SEC’s Public Reference Room at 100 F Street, NE, Washington, D.C. 20549. The public may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC also maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC. The address of that site is http://www.sec.gov. The address of the company’s website is www.owens-minor.com. Through a link to the SEC’s Internet site on the Investor Relations portion of our website, we make available all of our filings with the SEC, including our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those reports, as well as beneficial ownership reports filed with the SEC by directors, officers and other reporting persons relating to holdings in Owens & Minor, Inc. securities. This information is available as soon as the filing is accepted by the SEC. Corporate Governance The company’s Bylaws, Corporate Governance Guidelines, Code of Honor and the charters of the Audit, Compensation & Benefits, and Governance & Nominating Committees are available on the company’s website at www.owens-minor.com and are available in print to any shareholder upon request by writing to: Corporate Secretary Owens & Minor, Inc. 9120 Lockwood Boulevard Mechanicsville, Virginia 23116 Communications with the Board of Directors The Board of Directors has approved a process for shareholders to send communications to the Board. Shareholders can send written communications to the Board, any committee of the Board, the Lead Director or any other individual director at the following address: P.O. Box 26383, Richmond, Virginia 23260. Certifications The company’s Chief Executive Officer certified to the New York Stock Exchange (NYSE) within 30 days after the company’s 2013 Annual Meeting of Shareholders that he was not aware of any violation by the company of NYSE corporate governance listing standards. The company also filed with the SEC as exhibits 31.1, 31.2, 32.1 and 32.2 to its Annual Report on Form 10-K for the year ended December 31, 2013, certifications by its Chief Executive Officer and Chief Financial Officer. Our mission To create consistent value for our customers and supply-chain partners that will maximize shareholder value and long-term earnings growth; we will do this by managing our business with integrity and the highest ethical standards, while acting in a socially responsible manner with particular emphasis on the well-being of our teammates and the communities we serve. Our Vision Connecting the World of Medical Products to the Point of Care.TM Our Values We believe in high integrity as the guiding principle of doing business. We believe in our teammates and their well-being. We believe in providing superior customer service. We believe in supporting the communities we serve. We believe in delivering long-term value to our shareholders. Corporate Office 804-723-7000 www.owens-minor.com Street Address 9120 Lockwood Boulevard Mechanicsville, Virginia 23116 Mailing Address Post Office Box 27626 Richmond, Virginia 23261-7626 

Continue reading text version or see original annual report in PDF format above